{
  "url": "https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9",
  "title": "Improving fecal transplantation precision for enhanced maturation of intestinal function in germ-free mice through microencapsulation and probiotic intervention - Microbiome",
  "description": "Background Fecal microbiota transplantation (FMT) has emerged as a widely used treatment for various diseases. While previous efforts have focused on selecting “super donors”, the precise modulation of donor microbiota to enhance FMT efficacy remains a critical challenge. This study aimed to develop strategies to modify donor microbiota to promote gastrointestinal development and maturation in germ-free mice. Probiotic Pediococcus pentosaceus Li05 (Li05) was used as gut microbiota modulator to establish a healthier donor fecal microbiota, and a microencapsulation method was applied to ensure high bacterial viability during gastrointestinal tract transition. Results Probiotic intervention initially altered the stability of the gut microbiota but eventually fostered a more complex bacterial interaction network and established a new equilibrium within 14 days. Transplantation of encapsulated Li05-modulated fecal microbiota significantly promoted epithelial development, improved barrier function, and altered the colonic transcriptome profile. These effects were found to be more dependent on the abundance of some bacterial genera instead of their co-occurrence network, and the key functional bacterial genera associated with these benefits were believed to be Parabacteroides, Parasutterella, Lachnoclostridium, Muribaculum and Desulfovibrio. Notably, both encapsulation and probiotic modulation played critical roles in enhancing the functional efficacy of these key bacterial genera, and the community composed of key functional bacteria demonstrated an antagonistic relationship with other bacterial communities. Moreover, encapsulated Li05-modulated fecal microbiota induced dramatical changes in host lipid metabolism, especially the bile acids and their derives. Sporobiota gained the function of promoting epithelium development gene expression only after Li05-modulation since high abundance of Lachnoclostridium was introduced. Conclusion These findings underscore the importance of encapsulation and donor microbiota modulation in FMT and provide valuable strategies for improving transplantation precision and outcomes. Graphical Abstract Video Abstract",
  "links": [
    "https://link.springer.com/article/10.1186/s40168-025-02204-9",
    "https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9"
  ],
  "image": "https://static-content.springer.com/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Figa_HTML.png",
  "content": "<div>\n                                    <div><h2 id=\"Sec1\">Introduction</h2><div><p>The gut microbiota plays a critical role in various physiological and pathological processes in the host body by generating metabolites and interacting with gut tissue cells [<a target=\"_blank\" title=\"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020–32.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR1\">1</a>]. Disorder in the gut microbiota, either in composition or microbial abundance, is a crucial causative factor of intra- or extra- gastrointestinal diseases [<a target=\"_blank\" title=\"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020–32.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR1\">1</a>]. One of most direct and efficacious ways to modulate the gut microbiota is through fecal microbiota transplantation (FMT) [<a target=\"_blank\" title=\"Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol. 2022;20:365–80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR2\">2</a>], as have been successfully demonstrated though its application for <i>Clostridioides difficile</i> infection (CDI), which provided new insights into therapeutic value of gut microbiota modulation [<a target=\"_blank\" title=\"Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854–9.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR3\">3</a>]. As an emerging therapy, the selection and process of donors’ stool are crucial determinants of FMT efficacy [<a target=\"_blank\" title=\"Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host Microbe. 2023;31:712–33.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR4\">4</a>]. Although guidelines [<a target=\"_blank\" title=\"Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66:569–80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR5\">5</a>, <a target=\"_blank\" title=\"Parenteral and Enteral Nutrition Branch of Chinese Medical Association, Enhanced recovery after surgery branch of China International Health Care Promotion and Exchange Association, China Microecological Treatment Innovation Alliance, Microecology Committee of Shanghai Preventive Medicine Association. Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation. Chinese J Gastrointest Surg. 2020;23:5–13.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR6\">6</a>] for usage of FMT currently exist, and many cases of therapeutic usage have been documented [<a target=\"_blank\" title=\"Carvalho T. First oral fecal microbiota transplant therapy approved. Nat Med. 2023;29:1581–2.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR7\">7</a>], FMT remains controversial. Concerns about pathogen transmission and the difficulty to fully define the composition of fecal transplants currently limit further application of FMT. As a result, considerable effort has recently been directed at establishing methodologies for determination of microbial signatures of FMT donors [<a target=\"_blank\" title=\"Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host Microbe. 2023;31:712–33.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR4\">4</a>].\n</p><p>The rationale for application of FMT for treatment of intestinal diseases, such as CDI and inflammatory bowel disease (IBD), has its basis in its ability to enhance gut barrier function [<a target=\"_blank\" title=\"Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016;13:508–16.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR8\">8</a>,<a target=\"_blank\" title=\"Cheng S, Ma X, Geng S, Jiang X, Li Y, Hu L, et al. Fecal microbiota transplantation beneficially regulates intestinal mucosal autophagy and alleviates gut barrier injury. mSystems. 2018;3:e00137–18.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR9\">9</a>,<a target=\"_blank\" title=\"Huang Y, He K, Chen Y. Unraveling interactions between gut epithelium and microbiota using models of intestinal organoids. Infectious Microbes &amp; Diseases. 2024;6:117.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR10\">10</a>]. Given the link between the microbiota and the gut barrier [<a target=\"_blank\" title=\"Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77–94.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR11\">11</a>], screening for functional key bacteria with therapeutic value in FMT donor stool is worthwhile. Various methods of FMT [<a target=\"_blank\" title=\"McGovern BH, Ford CB, Henn MR, Pardi DS, Khanna S, Hohmann EL, et al. SER-109, an investigational microbiome drug to reduce recurrence after Clostridioides difficile Infection: lessons learned from a phase 2 trial. Clin Infect Dis. 2021;72:2132–40.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR12\">12</a>,<a target=\"_blank\" title=\"Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2016;315:142–9.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR13\">13</a>,<a target=\"_blank\" title=\"Yu Y, Wang W, Zhang F. The next generation fecal microbiota transplantation: to transplant bacteria or virome. Adv Sci. 2023;10:2301097.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR14\">14</a>,<a target=\"_blank\" title=\"Yang Y, He J, Wang Y, Liang L, Zhang Z, Tan X, et al. Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis. Front Immunol. 2023;14:1143526.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR15\">15</a>], including artificial synthetic bacterial community for regulating gut microbiota have been studied [<a target=\"_blank\" title=\"Brugiroux S, Beutler M, Pfann C, Garzetti D, Ruscheweyh H-J, Ring D, et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat Microbiol. 2016;2:1–12.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR16\">16</a>]. For instance, Yang et al. found that whole intestinal microbiota transplantation more effectively replicates donor communities and alleviates colitis in mice compared to transplantation of fecal microbiota [<a target=\"_blank\" title=\"Yang Y, He J, Wang Y, Liang L, Zhang Z, Tan X, et al. Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis. Front Immunol. 2023;14:1143526.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR15\">15</a>]. Probiotics, as one alternative to FMT in modeling gut microbiota [<a target=\"_blank\" title=\"Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol. 2022;20:365–80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR2\">2</a>], play a positive role in maintaining intestinal health. However, current existing donor inclusion and exclusion criteria lack consensus on probiotic supplementation restrictions [<a target=\"_blank\" title=\"Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66:569–80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR5\">5</a>, <a target=\"_blank\" title=\"Parenteral and Enteral Nutrition Branch of Chinese Medical Association, Enhanced recovery after surgery branch of China International Health Care Promotion and Exchange Association, China Microecological Treatment Innovation Alliance, Microecology Committee of Shanghai Preventive Medicine Association. Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation. Chinese J Gastrointest Surg. 2020;23:5–13.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR6\">6</a>, <a target=\"_blank\" title=\"Piekarska A, Panasiuk A, Stępień PM. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol—recommendations of the Polish Society od Epidemiology and Infectious Diseases. Przegl Epidemiol. 2020;74:69–87.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR17\">17</a>,<a target=\"_blank\" title=\"Peery AF, Kelly CR, Kao D, Vaughn BP, Lebwohl B, Singh S, et al. AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology. 2024;166:409–34.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR18\">18</a>,<a target=\"_blank\" title=\"Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019;68:2111–21.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR19\">19</a>,<a target=\"_blank\" title=\"van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021;27:S1-21.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR20\">20</a>,<a target=\"_blank\" title=\"Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2024;73:1–24.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR21\">21</a>]. Given that FMT efficacy depends critically on donor microbiota composition, probiotic intervention may modify the microbial composition of donor feces and affect FMT. However, the potential of probiotic-modulated microbiome in the context of FMT has not been thoroughly explored.</p><p>The primary methods for administering FMT include enema, endoscopic infusion, nasoenteric tube delivery, and oral administration. Traditional FMT routes demonstrate significant therapeutic efficacy, but their invasive nature and procedural complexity hinder widespread clinical adoption. In contrast, oral administration is widely regarded as the most promising delivery method due to its non-invasiveness, cost-effectiveness, and ease of use [<a target=\"_blank\" title=\"Gulati M, Singh SK, Corrie L, Kaur IP, Chandwani L. Delivery routes for faecal microbiota transplants: available, anticipated and aspired. Pharmacol Res. 2020;159: 104954.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR22\">22</a>, <a target=\"_blank\" title=\"Lee JY, Kim Y, Kim J, Kim JK. Fecal microbiota transplantation: indications, methods, and challenges. J Microbiol. 2024;62:1057–74.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR23\">23</a>]. However, a major challenge of oral FMT administration is to maintain the bacterial viability during gastrointestinal transit [<a target=\"_blank\" title=\"Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ, et al. Fecal microbiota transplantation: current challenges and future landscapes. Staley C, editor. Clin Microbiol Rev. 2024;37:e00060–22.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR24\">24</a>]. During FMT administration, fecal microbes will encounter the harsh environment composed by gastric acid, bile acid (BA) and digestive enzymes, which significantly diminish the bacteria’s survival rate and activity, subsequently impacting the outcome of the transplantation [<a target=\"_blank\" title=\"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020–32.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR1\">1</a>]. Thus, protecting the bacteria in the gastrointestinal tract is crucial for optimizing the therapeutic efficacy of FMT. Microencapsulation is an effective means to protect bacteria from harsh physical conditions during delivery process, but its application in FMT was rarely reported.</p><p>The aim of this study was to elucidate the role of FMT with probiotic-modulated stool on the gut microbiota and metabolism, as well as its impacts on the intestinal function in mice. The next generation probiotic strain <i>Pediococcus pentosaceus</i> Li05 (Li05) [<a target=\"_blank\" title=\"Jiang S, Cai L, Lv L, Li L. Pediococcus pentosaceus, a future additive or probiotic candidate. Microb Cell Fact. 2021;20:45.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR25\">25</a>] was supplemented to mice to obtain probiotic-modulated fecal donor microbiomes, while changes in the gut microbiomes were monitored. Additionally, spore-forming bacteria were obtained to further investigation of sporobiota in mice. To enhance gastrointestinal delivery of the vulnerable probiotic genera and improved the therapeutic efficacy of FMT, a microencapsulation method was used to incorporate the microbiota. Furthermore, multi-omics methods and a germ-free (GF) animal model was used to investigate and mechanistically link the effects of FMT on gut microbiota and host metabolism.</p></div></div><div><h2 id=\"Sec2\">Materials and methods</h2><div><h3 id=\"Sec3\">Bacteria strain and cultivation</h3><p>Li05 was extracted from healthy human feces as previously described [<a target=\"_blank\" title=\"Lv L, Hu X, Qian G, Zhang H, Lu H, Zheng B, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by d-galactosamine in rats. Appl Microbiol Biotechnol. 2014;98:5619–32.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR26\">26</a>] and cultivated in De Man, Rogosa, Sharpe broth medium(OXOID, Basingstoke, UK) overnight under anaerobic conditions (80% N<sub>2</sub>, 10% H<sub>2</sub>, 10% CO<sub>2</sub>) at 37 ℃. The culture broth was subsequently centrifugated at 3000 g for 10 min at 4 ℃ to pellet Li05 cells. The cell pellets were washed twice with normal saline before resuspension to a final concentration of 1.5 × 10<sup>10</sup> CFU/mL before further use.</p><h3 id=\"Sec4\">Feces donor mice and fecal collection</h3><p>Twenty-four male C57BL/6 mice (8 weeks old) were provided by the Laboratory Animal Center of Zhejiang Province (Zhejiang, China). The set-up of the mouse experiment is outlined in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>a. All mice were housed in specific-pathogen-free conditions at room temperature (~ 22 ℃) with a controlled 12-h:12-h light–dark cycle and given free access to normal food and water. After acclimation for 1 week, the animals were randomly divided into two groups: the control group (group N, <i>n</i> = 12) received normal saline, and the Li05 group (group L, <i>n</i> = 12) treated with Li05 suspension. The mice were administered a daily dosage of probiotics (3 × 10<sup>9</sup> CFU) for 2 weeks, and the body weights of the mice were recorded. On the  1 st, 3rd, 5th, 11th, and 14th day, fresh murine feces were individually weighted and collected in sterile tubes, then immediately transferred with dry ice to a -80 ℃ refrigerator.</p><div><figure><figcaption><b>Fig. 1</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/1\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig1_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig1_HTML.png\" alt=\"figure 1\" /></picture></a></div><p>Dynamic changes of gut microbiota after Li05 supplement in mice. <b>a</b> Gut microbiota co-occurrence networks with respect to Li05 supplement time in mice of L group and N group. In the networks, each node indicates a genus (colored according to the phylum), and its size indicates degree. Red and blue edges indicate positive and negative correlations between connected nodes, and the width of edges represents the magnitude of the correlation. Histograms show the degree distributions of nodes. <b>b</b>–<b>f</b> Topological features of gut microbiota co-occurrence networks, including number of nodes (<b>b</b>), number of edges (<b>c</b>), average degree (<b>d</b>), clustering coefficient (<b>e</b>), number of hub nodes (<b>f</b>), modularity (g), and number of modules (<b>h</b>). The N and L groups are indicated by blue and red, respectively. <b>i</b> The temporal changes of bacterial genera based on the Markov chain models were evaluated. The genera transition probabilities of consecutive feces collection points from absence to presence (inflow) or vice versa (outflow) were estimated to identify persistence colonizing genera and transient colonizing microbes</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/1\"><span>Full size image</span></a></p></figure></div><h3 id=\"Sec5\">Preparation of feces for fecal microbiota transplantation</h3><p>Fecal solutions used for the FMT experiments were prepared from murine donor feces collected on the 14th day. Feces from all mice in the same group were mixed and diluted at a ratio of 1:10 (w/v) with sterile 20% glycerol (prepared with normal saline) and then homogenized with a vortex for 1 min. Subsequently, fecal suspensions were obtained by filtration through a 100 μm cell strainer. All of the above steps were conducted in an anaerobic chamber (Coy laboratories, MI, USA) (80% N<sub>2</sub>, 10% H<sub>2</sub>, 10% CO<sub>2</sub>). The fecal bacterial suspension was then stored at -80 ℃ for future use.</p><h3 id=\"Sec6\">Preparation of fecal spores</h3><p>The fecal bacterial suspension was thawed in a water bath at 37 ℃ for 10 min, followed by spore isolation with ethanol according to a previously published protocol [<a target=\"_blank\" title=\"Koransky JR, Allen SD, Dowell VR. Use of ethanol for selective isolation of sporeforming microorganisms. Appl Environ Microbiol. 1978;35:762–5.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR27\">27</a>]. The suspension containing bacterial cells and spores was mixed with ethanol to 50% (wt/wt), incubated at 150 rpm in a KS4000i shaker (IKA, Staufen, Germany) at room temperature for 1 h, and centrifugated for 10 min at 3000 g. The resulting pellet was washed twice with normal saline to remove ethanol before resuspended in saline. The acquired spores were then pre-frozen in − 80 ℃ for 48 h, and subsequently lyophilized in a freezer dryer (FreeZone, Labconco, US) for 24 h, at − 80 ℃ and 0.300 millibars. The lyophilized spores were stored at − 80 ℃ for later use.</p><h3 id=\"Sec7\">Encapsulation of bacterial cells</h3><p>Fecal bacteria and pure cultures of Li05 were encapsulated as follows. First, 10 mL of carboxymethyl chitosan (Sigma-Aldrich, St. Louis, MO, USA) solution (2 mg/mL) was added to 2 mL of fecal bacterial suspension. The mixture was then incubated at 37 ℃ for 10 min at 100 rpm on a shaker (IKA). After centrifugation and washed twice with normal saline, bacterial cells were added to 10 mL of sodium alginate (Sigma-Aldrich) solution (2 mg/mL), and incubated at 37 ℃ for 10 min at 100 rpm. Then bacterial precipitates were resuspended in 10 mL saline. All of the above steps were conducted in an anaerobic chamber (Coy laboratories). Encapsulated bacterial cells were then obtained by stirring in solution 0.1 M CaCl<sub>2</sub> for 20 min at room temperature and collected through centrifugation and washing with saline solution.</p><h3 id=\"Sec8\">Characterization of encapsulated bacteria</h3><p>The average particle sizes of encapsulated bacterial cells were measured with an LS13320 laser particle size analyzer (Beckman Coulter, CA, US). Encapsulated Li05, unencapsulated Li05, fecal bacteria, and encapsulated fecal bacteria were pre-frozen at − 80 ℃ for 48 h and then lyophilized in a freeze dryer (FreeZone, Labconco, US) for a minimum of 20 h, at − 80 ℃ and 0.300 millibars. Lyophilized encapsulated cells were coated with gold before the morphologies were visualized with scanning electron microscopy (SU-8010, Hitachi, Japan).</p><h3 id=\"Sec9\">In vitro tolerance assays of encapsulated bacterial cells exposed to harsh conditions</h3><p>Stock solutions of simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) were prepared according to previously reported protocols [<a target=\"_blank\" title=\"Minekus M, Alminger M, Alvito P, Ballance S, Bohn T, Bourlieu C, et al. A standardised static in vitro digestion method suitable for food—an international consensus. Food Funct. 2014;5:1113–24.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR28\">28</a>, <a target=\"_blank\" title=\"Yao M, Wu J, Li B, Xiao H, McClements DJ, Li L. Microencapsulation of Lactobacillus salivarious Li01 for enhanced storage viability and targeted delivery to gut microbiota. Food Hydrocolloids. 2017;72:228–36.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR29\">29</a>]. Briefly, the SGF stock solution was prepared by dissolving 3.2 g pepsin (Aladdin, Shanghai, China), 2 g NaCl, and 7 mL HCl, in 1000 mL sterile, deionized water. The SIF stock solution was prepared by dissolving 6.8 g KH<sub>2</sub>PO<sub>4</sub>, 3 g bile salt, and 10 g trypsin (Aladdin), in 1000 mL sterile, deionized water. The pH of the SGF and SIF stock solutions were adjusted with 0.2 M HCl or 0.2 M NaOH to 1.2 and 6.8, respectively. The viability of encapsulated or unencapsulated Li05 cells was evaluated when exposed to SGF or SIF at the ratio of 1:1, and incubated at 37 °C at 100 rpm in a KS4000i shaker (IKA). Viable counts of the bacteria were recorded at predetermined time points (15, 30, 45, 60, 90, and 120 min) after SGF or SIF exposure by using the plate count method.</p><h3 id=\"Sec10\">Murine fecal microbiota transplantation experiments</h3><p>Forty-eight germ-free(GF) mice (8-week-old, male) were bred in a sterile isolator as previously described [<a target=\"_blank\" title=\"Qv L, Yang Z, Yao M, Mao S, Li Y, Zhang J, et al. Methods for establishment and maintenance of germ-free rat models. Front Microbiol. 2020;11:1148.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR30\">30</a>]. The mice were randomly distributed into seven groups, each consisting of 6–8 mice. The mice were divided into mice given saline (control group C), mice given fecal transplants from untreated mice (group NF) and from mice administered Li05 (group LF), mice given fecal transplants with encapsulated bacterial cells from untreated mice (group eNF) and from mice administered Li05 (group eLF), and mice treated with fecal spores originating from the untreated mice (group NS) and from mice treated with Li05 (group LS). Mice in all groups were fed the respective fecal transplants at day 1 and day 3 via a single oral gavage of 200 µL, except for group C which received saline. The mice were monitored daily and feces was collected at day 4 and day 14. Finally, on day 14, the mice were sacrificed and samples of blood, small intestine, and colon and colonic contents were collected for subsequent analysis.</p><h3 id=\"Sec11\">Histopathology and immunofluorescence analyses</h3><p>Sections of the distal colon tissue were collected from sacrificed mice and fixed in tissue fixation solution (4% paraformaldehyde) for 24 h, and subsequently embedded in paraffin, followed by sectioning at 4 μm forhematoxylin and eosin (H&amp;E) staining and Alcian blue/periodic acid-Schiff (AB/PAS) staining. The sections were then scanned with a PANNORAMIC 250 digital slide scanner (3DHISTECH, Budapest, Hungary). Five fields were randomly selected from each section, and the thickness of muscle and crypt depth were measured by using the Caseviewer software(3DHISTECH) and the positive cell area of goblet cells was counted by ImageJ software (ImageJ, MD, USA). Then the expression of the colonic stem cell marker leucine-rich repeat G-protein-coupled receptor 5 (Lgr5) and of the cell proliferation marker Ki67 was detected using immunofluorescence staining. The colonic sections were deparaffinized, rehydrated, washed, and placed in a citrate buffer solution (Biossci, Hubei, China) to repair antigens. After being pretreated with 3% H<sub>2</sub>O<sub>2</sub>for 30 min, the sections were blocked with goat serum(Boster, Wuhan, China)for 30 min at 37 ℃. Sections were incubated overnight at 4 ℃ with anti-Lgr5 antibody (1:100, Proteintech, Chicago, IL, USA). The sections were washed with TBST and incubated with a goat anti-rabbit antibody (1:2000, Boster) for 45 min, rewashed, and incubated with Cy5-tyramide working solution (Biossci) for 10 min. Then the sections were washed with eluent solution (Biossci) in a water bath at 42 ℃ for 20 min. We aspirated the secondary antibody and repeated staining procedures with anti-Ki67 antibody (1:400, CST, MA, USA). Slides were rinsed three times in TBST for 3 min each and covered with a DAPI coverslip (Solarbio, Beijing, China). The sections were then scanned with a PANNORAMIC 250 digital slide scanner (3DHISTECH) and images were captured with the Caseviewer software(3DHISTECH). The numbers of Lgr5<sup>+</sup> and Ki67<sup>+</sup> cells were counted by ImageJ software (ImageJ, MD, USA).</p><h3 id=\"Sec12\">Quantitative PCR assay</h3><p>Total RNA of the colonic tissue was extracted by using anRNeasy Plus Mini Kit (QIAGEN, Hilden, Japan) according to the manufacturer’s instructions. Then, 500 ng of purified RNA was subsequently reversed to cDNA by PrimeScript™ RT Master Mix (TaKaRa, Kusatsu, Japan).Total bacterial DNA was extracted from feces by using a DNeasy PowerSoil kit (QIAGEN, Hilden, Germany) following the manufacturer’s instructions.Real-time PCR amplification of the cDNA or DNAwas performed with TB Green Premix Ex Taq II (Takara, Kusatsu, Japan) and a QuantStudio 5 Quantitative Real-Time PCR System (Applied Biosystems, Waltham, MA, USA) with primers specific for the β-actin gene, tight junction protein 1 (<i>Tjp1</i>), claudin-4 (<i>Cldn4</i>), occludin (<i>Ocln</i>), <i>baiCD</i> and total bacteria primer pairs (<i>PRUN518</i>, <i>PRBA338</i>) (Table <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>). Relative expression was computed by using the 2<sup>−ΔΔCt</sup> method, and the expression was normalized to that of the β-actin gene or total bacteria primer pairs, which were used as a control respectively.</p><h3 id=\"Sec13\">16S rRNA gene sequencing for gut microbiota analysis</h3><p>Feces from every 2 donor mice were mixed together for 16S rRNA sequencing. Total bacterial DNA was extracted from feces and cecal contents by using a DNeasy PowerSoil kit (QIAGEN) following the manufacturer’s instructions, and its concentration was determined with a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). PCR amplification of the V3–V4 variable regions of the 16S rRNA genes was conducted with the primer pairs (343F: 5′-TACGGRAGGCAGCAG-3′; 798R: 5′-AGGGTATCTAATCCT-3′). After amplification, purification, and quantification, equal amounts of purified amplicons were pooled for subsequent sequencing. 16S amplicon sequencing and analysis was conducted by Shanghai OE Biotech (Shanghai, China). Raw sequencing data were in FASTQ format. Paired-end reads were processed by using the Cutadapt 2.6 software to detect and trim adapters. After trimming, low quality sequences were filtered, denoised, and merged, and chimeric reads were detected and trimmed by using DADA2 with the default parameters of QIIME2 (2020.11) [<a target=\"_blank\" title=\"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR31\">31</a>]. The final output consists of representative reads and the ASV abundance table. Representative reads of each ASV were selected by using the QIIME2 package [<a target=\"_blank\" title=\"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR32\">32</a>]. All representative reads were annotated and blasted against the Silva database Version 138 by using the q2-feature-classifier with the default parameters. The α-diversity based on the Shannon and Simpson index was used to evaluate microbial diversity, the principal coordinate analysis (PCoA) based on Binary-Jaccard was conducted to assess microbial community alternations, and linear discriminant analysis (LDA) effect size (LEfSe) was used to identify characteristic taxa between groups. The functional content and KEGG analysis of the microbiota metagenome were predicted by using the PICRUSt software package.</p><h3 id=\"Sec14\">Co-occurrence patterns in gut microbiota</h3><p>We analyzed the co-occurrence networks of gut microbiota in mice with reference to a previous reported method [<a target=\"_blank\" title=\"Liu J, Zhu S, Liu X, Yao P, Ge T, Zhang X-H. Spatiotemporal dynamics of the archaeal community in coastal sediments: assembly process and co-occurrence relationship. ISME J. 2020;14:1463–78.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR33\">33</a>]. The genera detected in more than 20% of all samples were retained in the network [<a target=\"_blank\" title=\"Liu J, Zhu S, Liu X, Yao P, Ge T, Zhang X-H. Spatiotemporal dynamics of the archaeal community in coastal sediments: assembly process and co-occurrence relationship. ISME J. 2020;14:1463–78.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR33\">33</a>]. We calculated the Spearman correlation coefficients (ρ) between genera using Hmisc package of R software (version 4.4.2) and a co-occurrence was considered to be valid if ρ &gt;|0.7| and <i>P</i> &lt; 0.05 [<a target=\"_blank\" title=\"Li M, Raza M, Song S, Hou L, Zhang Z-F, Gao M, et al. Application of culturomics in fungal isolation from mangrove sediments. Microbiome. 2023;11:272.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR34\">34</a>]. We then plotted the co-occurrence networks using Gephi software (version 0.10.1, Oracle, Austin, TX, USA) [<a target=\"_blank\" title=\"Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. Proceedings of the International AAAI Conference on Web and Social Media. 2009;3:361–2.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR35\">35</a>]. To characterize the topological features of the co-occurrence networks, we used R <i>igraph</i> package and analyzed the numbers of nodes and edges, average degree, degree distribution, clustering coefficient, and modularity in each network. In the co-occurrence networks, each node represented a genus, and each edge represented pairwise correlation between genera. Degree distribution was fitted to Poisson distribution or Power Law distribution using R software (<i>fitdistrplus</i> and <i>poweRlaw</i> packages). Furthermore, we defined the bacteria as hub nodes when their degrees exceeded the third quartile of the degree in a network.</p><h3 id=\"Sec15\">Gut microbiota stability after Li05 intervention-definition of persistent and transient colonizing genera</h3><p>We identified persistent colonizing genera (PCG) and transient colonizing genera (TCG) as previously described [<a target=\"_blank\" title=\"Lee S, Meslier V, Bidkhori G, Garcia-Guevara F, Etienne-Mesmin L, Clasen F, et al. Transient colonizing microbes promote gut dysbiosis and functional impairment. Npj Biofilms Microbiomes. 2024;10:80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR36\">36</a>]. First, we fitted all non-zero abundance of bacterial genera into gamma distribution after normalization using R <i>fitdistrplus</i> package to decide the detection limit. Then we counted the presence/absence of genus only when its abundance &gt; 1%. Presence/absence profiles were fitted into a two-state Markov chain model to estimate state transition probabilities between presence and absence (R <i>markovchain</i> package). Here, we estimated inflow probability of state transition from absence to presence, and outflow probability of state transition from presence to absence (R <i>survival</i> and <i>survminer</i> packages). Based on estimated inflow and outflow probabilities, we identified PCG (<i>P</i><sub><i>inflow</i></sub> &gt; 0.3, and <i>P</i><sub><i>outflow</i></sub> &lt; 0.3) and TCG (<i>P</i><sub><i>outflow</i></sub> &gt; 0.3 and <i>P</i><sub><i>inflow</i></sub> &lt; 0.3).</p><h3 id=\"Sec16\">Metabolomics analysis of colonic contents</h3><p>Sixty milligrams of colon content from each sample was dissolved in 600 μL methanol:water at a 1:4 (v/v) ratio, and then precooled at − 40 ℃ for 2 min. The mixture was homogenized (60 Hz, 2 min) with a tissue grinder (Wonbio-E, Shanghai, China), and sonicated in an ice water bath for 10 min, and incubated at − 40 ℃ for 2 h. After centrifugated for 10 min (12,000 rpm, 4 °C), 200 μL of supernatant was transferred into a liquid chromatography-mass spectrometry (LC–MS) injection vial for evaporation. The residue was dissolved in 300 μL methanol: water at a 1:4 (v/v) ratio, vortexed for 30 s, sonicated in an ice water bath for 3 min, and incubated at − 40 ℃ for 2 h. After centrifugation for 10 min at 12,000 rpm and 4 °C, the mixture was filtered with a 0.22 μM organic phase pinhole filter. Then, 150 μL of supernatant was aspirated with a syringe and transferred to LC injection vial, and stored at − 80 ℃ until LC–MS analysis. Quality control samples were prepared by mixing the extract of all samples in equal volume. All extraction reagents were precooled at − 20 ℃ before use. The analytical instrument used for the LC–MS was a system composed of Acquity UPLC I-Class plus (Waters, Milford, MA, USA)/QE Plus ultra-performance LC tandem high-resolution MS (Thermo Fisher Scientific, Waltham, MA, USA). The spectrum obtained by continuously plotting the intensity of the strongest ion in the chromatogram at each time point. Subsequently, the raw data was preprocessed using the metabolomics processing software Progenesis QI v3.0 (Nonlinear Dynamics, Newcastle, UK), and the identification of compounds was based on retention time, fragments, and isotope distribution by using The Human Metabolome Database, METLIN database, and LuMet Anmal local database. Partial least squares discriminant analysis (PLS-DA) of metabolite profiles was plotted with software SIMCA 14.1 (Umetrics, Umeå | Malmö, Sweden). Bioinformatic analysis was performed using the OECloud tools at <a target=\"_blank\" href=\"https://cloud.oebiotech.com/\">https://cloud.oebiotech.com</a>. Differential metabolites were screened with fold changes (FC) &gt; 2 or FC &lt; 0.5, and <i>P</i> &lt; 0.05, and further screened with Variable Importance in Projection (VIP) scores &gt; 2. Spearman’s correlations between differential genera and bile acids (BAs) or Fatty acids (FAs) were calculated by using the OmicStudio tools at <a target=\"_blank\" href=\"https://www.omicstudio.cn/\">https://www.omicstudio.cn</a>. And the correlation network was constructed by using Gephi software (Oracle). A correlation was considered to be valid if ρ &gt;|0.4| and <i>P</i> &lt; 0.05.</p><h3 id=\"Sec17\">Transcriptomic analysis</h3><p>Total RNA (1 μg) was used for following mRNA library preparation. Isolation of poly(A) mRNA was performed using Oligo(dT) beads. The mRNA fragmentation was performed using divalent cations and high temperature. Random Primers were then used for priming. First strand cDNA and the second-strand cDNA were synthesized. The purified double-stranded cDNA was then treated to repair both ends and add a dA-tailing in one reaction, followed by a T-A ligation to add adaptors to both ends. Size selection of Adaptor-ligated DNA was subsequently conducted using DNA Clean Beads. Each sample was amplified by PCR using P5 and P7 primers, and the resultant PCR products were validated. Finally, libraries with different indices were multiplexed and loaded on an Illumina HiSeq/Illumina Novaseq/MGI2000 sequencing instrument for sequencing in a 2 × 150 paired-end configuration according to manufacturer’s instructions. In order to remove technical sequences, pass filter data of fastq format were processed by Cutadapt (V1.9.1) to be high quality clean data. Then clean data were aligned to reference genome via software Hisat2 (v2.2.1) [<a target=\"_blank\" title=\"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357–60.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR37\">37</a>]. Reference genome sequences and gene model annotation files were downloaded from NCBI. Transcripts in FASTA format were converted from a known GFF annotation file and indexed correctly. Using this as a reference, HTSeq (v0.6.1) assessed gene and isoform expression levels from cleaned pair-end data [<a target=\"_blank\" title=\"Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinform. 2022;38:2943–5.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR38\">38</a>]. Differential expression analysis was conducted using DESeq2 package from Bioconductor [<a target=\"_blank\" title=\"Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR39\">39</a>, <a target=\"_blank\" title=\"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR40\">40</a>]. We used scripts in house to enrich significant differential expression gene in KEGG pathways [<a target=\"_blank\" title=\"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27:29–34.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR41\">41</a>].</p><h3 id=\"Sec18\">Statistical analysis</h3><p>Experiments were repeated at a minimum in triplicates, with data was presented as the mean ± standard deviation. Statistically significant differences between groups were evaluated by one-way ANOVA followed by Bonferroni’s post hoc test. Nonparametric ANOVA (Kruskal–Wallis test) followed by Tukey’s post hoc tests were applied for the data which were not normally distributed. Pearson’s correlations were calculated and the clustering correlation heatmap was constructed by using the OmicStudio tools at <a target=\"_blank\" href=\"https://www.omicstudio.cn/\">https://www.omicstudio.cn</a>. Statistical tests were conducted by using IBM SPSS Statistics 26.0, and figures were generated with GraphPad Prism version 8.0. Significant differences were considered at the three levels of <i>P</i> ≤ 0.05 (*), <i>P</i> ≤ 0.01 (**), and <i>P</i> ≤ 0.001 (***). Different letters (a, b, c, d, etc.) in each column indicate statistically significant difference to other groups (<i>P</i> &lt; 0.05).</p></div></div><div><h2 id=\"Sec19\">Results</h2><div><h3 id=\"Sec20\">Modulation of donor gut microbiota with <i>Pediococcus pentosaceus</i> Li05</h3><p>Healthy mice were fed with Li05 daily for two continuous weeks, and the structure of their fecal gut microbiota was monitored every other day (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>a). After 2 weeks, no significant difference in body weight were observed between the Li05-treated mice and the control group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>b). The PCoA revealed that the gut microbiota structure in the control group (N group) remained stable from day 3 to day14, with only a slight shift on day 1(Fig.<a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>c). In contrast, dramatical changes were found in gut microbiota with Li05 intervention, especially on day 14 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>d-e), suggesting that Li05 modulation altered gut microbiota patterns in mice.</p><p>To detail the dynamic changes of synergistic and antagonistic relationships within the gut microbial community during Li05 modulation, co-occurrence networks were constructed for the mice of N and L groups at different time points (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>a). In these networks, nodes represent bacterial genera, and edges represent their correlations. In the N group, the node degree distributions of co-occurrence networks from day 1 to day 14 followed a Poisson distribution, reflecting random network characteristics of gut bacterial interactions. In contrast, the node degree distribution in the L group initially followed a Power Law distribution on day 1 but shifted to a Poisson distribution by day 3, which persisted until day 14. This transition indicates that the gut bacterial interaction networks initially exhibited scale-free network properties after Li05 intervention but rapidly reverted to random network characteristics. Furthermore, compared to N group, L group exhibited fewer nodes but more edges on day 14 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>b, c), and the average degree and clustering coefficient of L group were also higher than those of N group, suggesting more closely intertwined bacterial interactions (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>d, e). In addition, the number of hub genera within the microbiota network fluctuated over time (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>f).</p><p>The microbiota interaction networks demonstrated modular structures on day 14(modularity &gt; 0.4), and the bacterial genera in N and L groups were clustered into 8 and 6 modules, respectively (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>g, h). There were two large modules (modules 1 and 2) in the microbiota co-occurrence network of the N group on day 14, containing 20 nodes (5 phyla) and 18 nodes (3 phyla) respectively. In L group, the largest module (Module 1) contained 32 nodes (6 phyla), and these nodes exhibited a relatively complex associative structure with more nodes and connections involved.</p><p>To observe the disappearance and emergence of bacteria involved in the process of microbial community evolution, we analyzed gut microbial stability under Li05 intervention using Markov chain models applied to bacterial genera (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>g, h). In N group, 50 PCG and 87 TCG were identified, while in the Li05-modulated group, 44 PCG and 104 TCG were observed (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig1\">1</a>i). Among these, 37 PCG were shared between two groups, and 7 PCG were unique to L group, including <i>Desulfovibrio</i>, <i>Clostridia vadinBB60</i> group, <i>Tuzzerella</i>, <i>Gallionella</i>, <i>Stenotrophomonas</i>, UCG-009, and Family XIII AD3011 group. In the co-occurrence network, the connections generated by PCG predominated, accounting for 73.4% of the N group and 64.4% of the L group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S1</a>i). Notably, over half of these PCG connections were positively correlated. And significantly more connections between PCG and TCG were observed in L group compared to N group.</p><h3 id=\"Sec21\">Effect of FMT with encapsulated bacterial cells on gut epithelial development and barrier function</h3><p>Fecal bacterial cells from donor groups (N and L) were encapsulated using a microencapsulation method to protect them from the harsh environment of the gastrointestinal tract (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>a and <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S2</a>a). Protective layers surrounding the surface of fecal bacterial cells was confirmed through microscopic observation (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S2</a>b), with the average particle size measured at 73.34 ± 5.91 μm (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S2</a>c). This microencapsulation method significantly improved the survival rate of Li05 bacterial cells during long-time storage (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S2</a>d) and enhanced their viability under simulated gastrointestinal conditions compared to unencapsulated bacterial cells (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S2</a>e, f).</p><div><figure><figcaption><b>Fig. 2</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/2\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig2_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig2_HTML.png\" alt=\"figure 2\" /></picture></a></div><p>Effects of encapsulated FMT on receiver mice. <b>a</b> Schematic representation of experimental design. Fecal microbes’ suspension was treated to GF mice directly or after microencapsulation, the GF mice were treated twice on day 1 and day 3, while the control mice were treated with saline. Feces were collected on day 4 and day 14. <b>b</b>, <b>c</b> Body weight and colon length on day 14 after FMT of each group. <b>d</b> Representative photographs of colon H&amp;E, AB/PAS, and Lgr5<sup>+</sup>/Ki67<sup>+</sup>staining (Scale bar = 50 μm).<b> e</b>, <b>h</b> Quantification of colonic crypt depth (<b>e</b>), AB/PAS<sup>+</sup> cells (<b>f</b>), Lgr5<sup>+</sup> cells (<b>g</b>), and Ki67<sup>+</sup> cells (<b>h</b>). <b>i</b> Relative expression of colonic tight junction proteins related genes <i>Tjp 1</i>,<i> Cldn4</i>, and <i>Ocln</i> after FMT. <b>j</b> Volcano plot of differential differentially expressed genes (DEGs) between eLF and LF group. Red and blue dots represented upregulated and downregulated genes in eLF group compared to LF group, and gray dots represented nondifferential gene. <b>k</b> Correlation analysis between mice characteristics and colonic transcript profiles. Positive correlations are represented in red, and negative correlations are represented in blue. Significant differences are denoted by *<i>P</i> &lt; 0.05. Data are shown as the mean ± SD. Significant differences are denoted by *<i>P</i> &lt; 0.05, **<i>P</i> &lt; 0.01; ***<i>P</i> &lt; 0.001; <i>ns</i> not significant</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/2\"><span>Full size image</span></a></p></figure></div><p>Following FMT administration in GF mice, a significant increase in body weight was observed in the encapsulated FMT groups (eNF and eLF) compared to the unencapsulated groups (NF and LF) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>b, <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">P</a> &lt; 0.05). Colon lengths were also longer in mice receiving encapsulated fecal transplants (especially eLF group) compared to the Control group (C) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>c, <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">P</a> &lt; 0.05). FMT appeared to induce histomorphological changes in the colonic tissues of GF mice. As shown in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S3</a>a, GF mice in the C group exhibited a noticeably bloated cecum. In contrast, in mice of all experiment groups, the intestinal distention relieved, and the cecum reduced to almost 1/6 the size of mice in C group, with denser intestinal contents. Colonic morphological development was shown in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>d. H&amp;E staining showed smaller colonic epithelium and more organized colonic tissue in FMT groups than in GF mice of C group. Colon crypt depth was improved in all experiment groups relative to the C group, with no significant differences among encapsulated FMT groups and unencapsulated FMT groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>e). AB/PAS staining revealed substantially more goblet cells (mucin-containing, blue) in encapsulated FMT groups than in other groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>d, f). The number of Lgr5<sup>+</sup> cells (red), identified as stem cells of the gut epithelium, was highest in eLF group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>d, g). Ki67<sup>+</sup> cells (green) indicated proliferative activity and epithelial renewal and more of these cells were found in encapsulated FMT groups than other groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>d, h).</p><div><figure><figcaption><b>Fig. 3</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/3\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig3_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig3_HTML.png\" alt=\"figure 3\" /></picture></a></div><p>Gut microbiota structure and key bacterial genera among mice after FMT. <b>a</b> Variation of α-diversity of gut microbiota among four FMT groups evaluated by Simpson index. <b>b</b> β-diversity of gut microbiota was analyzed by using PCoA based on the Bray–Curtis distance. <b>c</b> Relative abundance of the most abundant bacteria ranked top 15 at the genus level. <b>d</b> Relative abundance of five key bacterial genera abundant in encapsulated FMT groups, including<i> Parabacteroides</i>,<i> Parasutterella</i>,<i> Lachnoclostridium</i>,<i> Muribaculum</i>, and<i> Desulfovibrio.</i> <b>e</b> Positively correlated associations among mice characteristics, DEGs and key bacterial genera. Different letters a, b, and c indicate significant differences at <i>P</i> &lt; 0.05</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/3\"><span>Full size image</span></a></p></figure></div><p>To evaluate the mechanical barrier function of the gut, mRNA expression levels of tight junction protein 1 (<i>Tjp1</i>), claudin-4 (<i>Cldn4</i>), and occludin (<i>Ocln</i>) in colonic tissues were measured (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>i). Notably, the expression of <i>Tjp1</i>, <i>Cldn4</i>, and <i>Ocln</i> was significantly higher among mice in the eLF group compared to the C group (<i>P</i> &lt; 0.05). Mice in the encapsulated FMT groups (eNF and eLF) exhibited elevated <i>Tjp1</i> expression compared to the unencapsulated FMT groups (NF and LF) (<i>P</i> &lt; 0.05). The expression of <i>Cldn4</i> was also higher in the eLF group compared to the LF group. And <i>Ocln</i> expression in eLF group was the highest than other groups, especially relative to the C group (<i>P</i> &lt; 0.05). These findings highlight the prominent enhancement of gut barrier function in encapsulated FMT groups.</p><p>To explore the effects of introduced gut microbiota on gastrointestinal development, we quantified the gene expression profiles of colon in receiver mice by RNA sequencing analysis. Transcriptome profiling revealed a total of 22,173 expressed genes. Compared to C group, 2410 differentially expressed genes (DEGs, log<sub>2</sub>FC ≥|1|,<i> P</i> &lt; 0.05) were detected in the eLF group, the highest number among all groups relative to C group (Fig.<a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\"> S3</a>b).</p><p>Compared to LF group, 1076 DEGs were identified in eLF group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>j), with the top 40 of them were listed in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S3</a>c. Given the positive effect of eNF and eLF groups on improving gut barrier function and epithelial development, genes that exhibited consistent upregulation or downregulation in both encapsulated FMT groups relative to LF group were correlated to host traits (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig2\">2</a>k). Among these, 17 genes showed positive correlations with host traits. KEGG enrichment analysis revealed that the highest number of differential genes were linked to metabolic pathways (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S3</a>d).</p><h3 id=\"Sec22\">Key bacterial genera and co-occurrence network after FMT</h3><p>This section investigated the gut microbiota structure following FMT, with a particular focus on the effects of Li05-modulated donor microbiota and microencapsulation. Analysis of α-diversity (Simpson indices) revealed no significant differences among groups on day 4 post-FMT, whereas species diversity of gut microbiota was significantly lower in the encapsulated FMT groups (eNF and eLF) on day 14 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>a, <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">P</a> &lt; 0.05). The PCoA analysis unveiled statistically significant variations in microbial community structures over time among four groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>b, <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">P</a> &lt; 0.01), with distinct β-diversity patterns were found, especially on day 14. Interestingly, the PCoA revealed overlapping bacterial component profiles between NF and eNF groups, while distinct clustering was observed between Li05-modulated groups (LF and eLF), especially on day 14.</p><p>The structure of gut microbiota was monitored on days 4 and 14 post-FMT (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>c and <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S4</a>a). The differences in bacterial taxa among four FMT groups on day 4 and day 14 were identified respectively. Specifically, the relative abundance of <i>Parabacteroides</i>, <i>Parasutterella</i>, <i>Lachnoclostridium</i>, <i>Muribaculum</i>, and <i>Desulfovibrio</i> were notably high in eLF group on day 14, with <i>Parabacteroides</i> and <i>Parasutterella</i> also abundant in eNF group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>d), indicating that their abundance were strongly dependent on microencapsulation. The abundance of <i>Muribaculaceae</i> was the highest in the eLF group compared to other FMT groups, while no difference was observed between the NF and eLF groups on day 14 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S4</a>b). The abundance of <i>Bacteroides</i> was the lowest in eLF group on day 14. Interestingly, the abundance of <i>Lactobacillus</i> in eLF group was the highest compared to other groups on day 4, but its abundance decreased over time and showed no difference on day 14. The bacterial genera ranking top 15 in abundance on day 14 were correlated with morphological features and gut epithelial characteristics of mice (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S4</a>c). These results demonstrated that the abundance of key bacterial genera (<i>Parabacteroides</i>, <i>Parasutterella</i>, <i>Lachnoclostridium</i>, <i>Muribaculum</i>, and <i>Desulfovibrio</i>) were positively associated with the expression of tight junction proteins. Furthermore, the abundance of these key bacterial genera were positively correlated with DEGs related to gut epithelial development, and the positive relationships among morphological features, genes, and key bacterial genera were shown in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>e.</p><p>Gut microbiota co-occurrence networks on days 4 and 14 among mice in four FMT groups were constructed (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig4\">4</a>a). The node degree distribution of the gut bacterial interaction network in FMT groups followed the Poisson distribution, indicating random network features, except for the eNF group on day 14, which conformed to the Power law distribution featuring scale-free network. More edges were found in the gut microbiota co-occurrence network of eNF group on day 14 compared to other groups. Compared to NF group, eNF group had larger number of nodes and edges on day 14, indicating a more complicated network involving more gut microbial genera (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig4\">4</a>b, c). In contrast, eLF group showed fewer nodes and edges compared to LF group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig4\">4</a>b, c). Interestingly, the changes in average degree, clustering coefficient, and number of hub nodes in eLF group from day 4 to day 14 showed an opposite trend compared to LF and eNF groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig4\">4</a>d–f). According to the node degrees, we further explored the hub genera in the gut microbiota co-occurrence networks. On day 14, <i>Clostridia</i> UCG-014 (NF), <i>Eubacterium xylanophilum</i> group (eNF), <i>Ileibacterium</i> (LF), and <i>Lachnospiraceae</i> NK4A136 group (eLF) had the highest degree in their respective groups, ranking as the top hub nodes. Notably, the genus <i>Eubacterium xylanophilum</i> group, belonging to <i>Lachnospiraceae</i> family, was absent from co-occurrence network of eNF group on day 4, suggesting it may have a slow colonization rate in the microbial community of eNF group. Other hub genera in the networks were listed in Supplementary Table 2.</p><div><figure><figcaption><b>Fig. 4</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/4\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig4_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig4_HTML.png\" alt=\"figure 4\" /></picture></a></div><p>Analysis of gut microbiota co-occurrence networks between FMT groups. <b>a</b> Gut microbiota co-occurrence networks among mice after FMT, each node indicates a genus, and its size indicates degree. Red and blue edges indicate positive and negative correlations, respectively. Histograms show the degree distributions of nodes. <b>b</b>–<b>h</b> Topological features of gut microbiota co-occurrence networks, including number of nodes (<b>b</b>), number of edges (<b>c</b>), average degree (<b>d</b>), clustering coefficient (<b>e</b>), hub nodes (<b>f</b>), modularity (<b>g</b>), and number of modules (<b>h</b>). The eNF and eLF groups are indicated by blue and red, and the NF and LF groups are indicated by light blue and light red, respectively</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/4\"><span>Full size image</span></a></p></figure></div><p>The co-occurrence networks of all four groups exhibited modular structures (modularity &gt; 0.4) and the nodes were clustered into 8 (NF), 5 (eNF), 9 (LF), and 8 (eLF) bacterial modules on day 14 respectively (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig4\">4</a>g–h). Modules containing 15 or more nodes were analyzed. The largest bacterial module in eNF group contained 22 nodes from 5 phyla. In comparison, the largest modules in the NF, LF, and eLF groups contained 16 nodes (from 4 phyla), 16 nodes (from 2 phyla), and 15 nodes (from 3 phyla), respectively. Most of the genera within the largest modules across all groups were from the Firmicutes phylum.</p><h3 id=\"Sec23\">Metabolomic profiles of mice treated after fecal transplantation</h3><p>Untargeted metabolomics analysis of colonic content was performed to elucidate how different types of gut microbiota affect the host metabolism. A total of 7,675 metabolites (3,911 in negative ion mode and 3,764 in positive ion mode) were detected among all groups’ samples. PLS-DA analysis revealed considerable overlaps in metabolites between NF and LF groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>a). In contrast, metabolic profiles of eNF and eLF groups were obviously separated from those of unencapsulated FMT groups.</p><div><figure><figcaption><b>Fig. 5</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/5\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig5_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig5_HTML.png\" alt=\"figure 5\" /></picture></a></div><p>Effects of Li05-modulated microbiota on recipient mice metabolism after FMT. <b>a</b> PLS-DA analysis of untargeted metabolomics results showed significant separation of metabolic profiles among groups. <b>b </b>Differential metabolites (FC &gt; 2 or FC &lt; 0.5, <i>P</i> &lt; 0.05) between groups were classified into 7 main categories, the largest number of differential metabolites was found to be in lipid metabolism. <b>c</b> Volcano plots showed the differential lipids and lipid-like molecules across groups, and top 10 molecules were labeled. Blue dots, gray dots, and red dots represented molecules downregulated, with no significant changes, and upregulated, respectively. <b>d</b> Heatmap of differential BAs and derivatives profile (left) and differential FAs and conjugates profile (right). The color from blue to red indicates that the abundance of metabolites ranged from low to high. <b>e</b>, <b>f</b> Relative concentrations of total BAs and total SBAs among mice after FMT. <b>g</b> The expression of <i>baiCD</i> gene in mice feces. <b>h</b>, <b>i</b> Network interactions between the differential bacterial genera and differential BAs (<b>h</b>) or differential FAs (<b>i</b>). Nodes represented bacterial genera (blue), key bacterial genera (dark blue), BAs (yellow), key BAs (orange), and FAs (pink), respectively. Node size represents the number of connections of a given genus or metabolite within the network. Significant differences are denoted by *<i>P</i> &lt; 0.05, **<i>P</i> &lt; 0.01; ***<i>P</i> &lt; 0.001; <i>ns</i> not significant</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/5\"><span>Full size image</span></a></p></figure></div><p>Compared to LF group, eLF group exhibited a total of 1,647 differential metabolites. These metabolites were categorized into seven major classes, with 502 metabolites involved in lipid metabolism (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>b). Notably, as many as 51 metabolites were bile acids (BAs) or their derivatives. Lipids and lipid-like molecules account for the greatest portion of differential metabolites between groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>b and <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S5</a>a).</p><p>PLS-DA was performed to assess lipid metabolic differences among groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S5</a>b). In the lipids and lipid-like molecules profile, the sample clusters from encapsulated groups (eLF and eNF) overlapped and were distinct from those of unencapsulated groups (LF and NF). The clusters of samples from LF and NF groups were very close. Fatty acids (FAs) and their conjugates, as major components of lipids and lipid-like molecules, showed the same trend as overall lipid profile. Interestingly, for the BAs and derivatives, the cluster of eLF group was separated from other three experimental groups, which are merged. Additionally, the top 10 significant differential lipids and lipid-like molecules were shown in volcano plots (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>c). KEGG enrichment analysis of metabolomic data showed the top 20 enriched pathways in each group, among which we compared the enrichment of lipid related pathways, especially pathways related to BA metabolism (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S5</a>c–f). Compared to LF group, a quarter of the top 20 enriched pathways in eLF group were related to lipid metabolism, and four of them were also enriched compared to eNF group. Without encapsulation, only the arachidonic acid metabolism pathway was enriched in LF group compared to NF group.</p><p>Differential BAs and FAs were further analyzed. As shown in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>d, the differential BA profile exhibited a significant enrichment in the number of BAs in eLF group compared to other groups. LF and eNF groups also showed increased levels of certain BAs compared to the NF group, while their BAprofiles differed notably from that of the eLF group. Besides, FA profiles revealed significant differences between encapsulated and unencapsulated FMT conditions.</p><p>The total BA concentration was the highest in eLF group among all groups, and total concentration of secondary bile acids (SBAs) were improved in all FMT groups compared to Control group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>e, f, <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">P</a> &lt; 0.05). Thus, we measured the expression of <i>baiCD</i>, a microbial gene cluster participating in 7α-dehydroxylation which involved in the production of SBA(Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>g). The abundance of <i>baiCD</i> was significantly higher in fecal samples from the eLF group compared to LF and NF groups (<i>P</i> &lt; 0.05). Key BAs, defined as those with higher relative concentrations in encapsulated FMT groups (eNF and eLF) than in unencapsulated groups (NF and LF), were listed in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S5</a>g, h. In eLF group, elevated BAs included 5 primary bile acids (PBAs) and 6 SBAs: α-muricholic acid (αMCA), β-muricholic acid (βMCA), cholic acid (CA), hyocholic acid (HCA) and glycohyocholic acid (GHCA), along with deoxycholic acid glycine conjugate (DCA-GC), ursocholic acid (UCA), 24-nor ursodeoxycholic acid (24-norUDCA), chenodeoxycholic acid sulfate (CDCA-S), taurodehydrocholic acid (TDHCA), and 3-oxocholic acid(3-oxoCA). Among them, the levels of CDCA-S, TDHCA, and 3-oxoCA were also significantly high in eNF group.</p><p>Since the BAs and FAs were the primary differential lipid metabolites upregulated in eLF and eNF groups compared to unencapsulated FMT groups, correlation network analysis was performed to explore the relationship between gut microbiota and lipid related metabolites (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>h, i). <i>Clostridia</i> UCG-014 was the genus correlated with the largest number of BAs and their derivatives, while 80.7% of their relationships were negatively correlated. <i>Parasutterella</i>, <i>Muribaculum</i>, <i>Prevotellaceae</i> UCG-001, and <i>Eubacterium xylanophilum</i> group ranked top in the number correlated with BAs and their derivatives. The former two genera were considered as key bacterial genera related to colonic epithelial homeostasis, and most of their correlations with BAs were positive (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>h). <i>Eubacterium xylanophilum</i> group, the hub node in the co-occurrence network of eNF group, was correlated with 23 types of BAs. Other key bacterial genera, including <i>Desulfovibrio</i>, <i>Parabacteroides</i>, and <i>Lachnoclostridium</i>, were also correlated with some BAs or their derivatives. Sulfolithocholic acid was correlated with more differential bacterial genera than the remaining molecules. Additionally, the relationship between key BAs and bacterial genera was also depicted in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>h. The aforementioned bacterial genera <i>Parasutterella</i>, <i>Prevotellaceae</i> UCG-001, <i>Eubacterium xylanophilum group</i>, and <i>Clostridia</i> UCG-014 were also correlated with most of FAs, highlighting their role in modulating lipid metabolism (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig5\">5</a>i).</p><h3 id=\"Sec24\">The role of sporobiota in promoting gut epithelial development</h3><p>In this section, the effects of bacterial spores isolated from fecal samples of N and L on gut epithelial development and barrier function were evaluated (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>a). After transplantation of fecal spores into GF mice, the body weight on day 14 showed no difference among Control, NS and LS groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>b). Compared to GF mice in Control group, intestinal distention was relieved, the size of cecum reduced, and intestinal contents were denser in mice of sporobiota transplantation groups (Fig.<a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\"> S6</a>a). Besides, no apparent improvement in colon length was observed in either NS group or LS group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S6</a>b). While a higher number of AB/PAS<sup>+</sup> goblet cells (blue), Lgr5<sup>+</sup> cells (red), and Ki67<sup>+</sup> cells (green) were found in LS group compared to Control group or NS group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>c–f). The expression of <i>Tjp1</i> and <i>Ocln</i> in the colon was lower in NS and LS groups compared to the control group, while <i>Cldn4</i> expression was elevated in LS group compared to NS group (<i>P</i> &lt; 0.05) (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>g). Transcriptome profiling revealed 485 DEGs in colonic tissue of LS group compared to LF group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>h). Ten of these DEGs, which were positively correlated with host features and key bacterial genera discussed earlier in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig3\">3</a>e, showed a notable enrichment in LS group compared to LF group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>i). Among them, the expression of <i>Ciart</i>, <i>Cyp51</i>, <i>Gm3776</i>, <i>Gsta1</i>, and <i>Zfp791</i> showed positive correlation with the number of AB/PAS<sup>+</sup> cells (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig6\">6</a>j). <i>Ciart</i>, <i>Gm3776</i>, and <i>Gsta1</i> expression also correlated positively with the ratio of Ki67<sup>+</sup> cells, while <i>Ciart</i>, <i>Cnpy1</i>, and <i>Gm3776</i> were positively related to the ratio of Lgr5<sup>+</sup> cells.</p><div><figure><figcaption><b>Fig. 6</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/6\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig6_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig6_HTML.png\" alt=\"figure 6\" /></picture></a></div><p>Effects of sporobiota transplantations on gut epithelial development. <b>a</b> Two types of fecal spores from donor N and L groups were obtained and transplanted to GF mice. <b>b</b> Sporobiota transplantation didn’t change body weight among mice. <b>c</b> The representative photographs of colon HE, AB/PAS, and Lgr5<sup>+</sup>/Ki67<sup>+</sup>staining (Scale bar = 50 μm). <b>d</b>–<b>f</b> Quantification of AB/PAS<sup>+</sup> cells (<b>d</b>), Lgr5<sup>+</sup> cells (<b>e</b>), and Ki67<sup>+</sup> cells (<b>f</b>). <b>g</b> Relative expression of colonic tight junction proteins related genes <i>Tjp 1</i>,<i> Ocln</i>, and <i>Cldn4</i> after sporobiota transplantation. <b>h</b> Volcano plot of DEGs between LS and LF group. Red and blue dots represented upregulated and downregulated genes in LS group compared to LF group, and gray dots represented nondifferential gene. <b>i</b> Heatmap of upregulated DEGs in LS group compared to LF group. <b>j</b> Correlation analysis between upregulated DEGs and receiver mice characteristics. Positive correlations are represented in red, and negative correlations are represented in blue. Significant differences are denoted by *<i>P</i> &lt; 0.05, **<i>P</i> &lt; 0.01; ***<i>P</i> &lt; 0.001; ****<i>P</i> &lt; 0.0001; ns, not significant</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/6\"><span>Full size image</span></a></p></figure></div><p>Given the negative impact of sporobiota in the NS group on gut epithelial development and barrier function, gut microbiota in mice of sporobiota transplantation groups were further analyzed. Following FMT, Firmicutes were the dominant bacteria at the phylum level in both groups (NS and LS), constituting the primary components of gut sporobiota (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S6</a>c). Specifically, Firmicutes comprised 99.74% of the total microbial abundance in LS group on day 14, while NS group comprised of 98.64% Firmicutes and 1.11% Actinobacteriota. The most abundant bacterial genera in both groups belonged to Clostridia class (Fig. S6d), with <i>Clostridia</i> UCG-014 and <i>Lachnospiraceae</i> NK4A136 group being the most abundant genera in NS and LS groups, respectively (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>a). LEfSe analysis identified 29 differential bacterial genera between NS and LS groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S6</a>e). The relative abundance of the above key bacterial genera <i>Parabacteroides</i>, <i>Parasutterella</i>, <i>Muribaculum</i>, and <i>Desulfovibrio</i> showed no differences between NS and LS groups, whereas the abundance of <i>Lachnoclostridium</i> was higher in LS group compared to NS group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>b). Additionally, DEGs including <i>Ciart</i>, <i>Cnpy1</i>, and <i>Gm3776</i> were positively correlated with <i>Lachnoclostridium</i> (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>c).</p><div><figure><figcaption><b>Fig. 7</b></figcaption><div><div><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/7\"><picture><source type=\"image/webp\" srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig7_HTML.png?as=webp\"></source><img src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40168-025-02204-9/MediaObjects/40168_2025_2204_Fig7_HTML.png\" alt=\"figure 7\" /></picture></a></div><p>Effects of sporobiota transplantation on gut microbiota and metabolomic features in mice. <b>a</b> The relative abundance of the top 15 most abundant genera in gut microbiota from NS and LS groups after FMT. <b>b</b> The relative abundance of 5 key bacterial genera in mice from NS and LS groups on day 14. <b>c</b> Positively correlated associations among mice characteristics, DEGs and <i>Lachnoclostridium</i>. <b>d</b> The co-occurrence network of gut microbiota among mice after sporobiota transplantation. Histograms show the degree distributions of nodes of the networks. <b>e</b>–<b>k</b> Topological features of gut microbiota co-occurrence networks, including number of nodes (<b>e</b>), number of edges (<b>f</b>), average degree (<b>g</b>), clustering coefficient (<b>h</b>), number of hub nodes (<b>i</b>), modularity (<b>j</b>), and number of modules (<b>k</b>). <b>l</b> PLS-DA analysis of untargeted metabolomics results showed significant separation of metabolic profiles among C, LS, and NS groups. <b>m </b>A total of 1,436 differential metabolites (FC &gt; 2 or FC &lt; 0.5,<b> P</b> &lt; 0.05) between LS and NS groups were classified into 7 main categories, and the category with the largest number is lipids and lipid-like molecules with 343 molecules involved.<b> n</b> Heatmap of differential BAs and derivatives. The color from blue to red indicates that the abundance of metabolites ranged from low to high. <b>o</b>, <b>p</b> Relative concentrations of total BAs and total SBAs among mice of Control, NS, and LS groups. <b>q</b> The expression of <i>baiCD</i> gene in mice feces. <b>r</b> The correlation analysis between the key differential BAs and <i>Lachnoclostridium</i>. Significant differences are denoted by *<i>P</i> &lt; 0.05, **<i>P</i> &lt; 0.01; ***<i>P</i> &lt; 0.001;<b> ns</b> not significant</p></div><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9/figures/7\"><span>Full size image</span></a></p></figure></div><p>The co-occurrence networks of NS and LS groups exhibited distinct features of gut microbiota interactions. The degree distribution of both NS and LS groups conformed to Power Law distribution on day 4, but it converted to Poisson distribution on day 14, indicating the network changed from scale-free networks to random networks (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>d). Notably, the variations of gut microbiota co-occurrence network exhibited an opposite trend from day 4 to day 14 between two groups, in terms of the number of nodes, number of edges, average degree, clustering coefficient, modularity and number of modules (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>e–h, j, k). The number of hub genera decreased in both groups by day 14, with LS group showing fewer hub genera compared to NS group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>i).</p><h3 id=\"Sec25\">Bacteria-metabolite interactions in mice after sporobiota transplantation</h3><p>Gut microbiota metabolite signatures following sporobiota transplantation were illustrated in this section. Distinct clustering patterns of metabolites were observed among mice of C, NS, and LS groups. A total of 1,436 differential metabolites were identified between LS and NS groups, including 343 lipids and lipid-like molecules, two-thirds of which were upregulated in the LS group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>m). The differential metabolite profile of BAs and derivatives clearly showed that more BAs were enriched in LS group than in NS group (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>n). Moreover, levels of total BAs, SBAs and <i>baiCD</i> gene expression in gut microbiota were highest in LS group among groups (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>o–q). The key BAs mentioned above in encapsulated groups were then correlated with <i>Lachnoclostridium</i>, where the abundance of DCA-GC and βMCA showed positive correlation with <i>Lachnoclostridium</i> (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>r).</p><h3 id=\"Sec26\">Categorization of bacterial communities</h3><p>All the differential bacterial genera among six FMT groups were listed in Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S7</a>a, classified into four bacterial communities. Group 1 includes bacterial genera shared by more than three groups. Group 2 is comprised of sporobiota existing in NS or LS groups. Group 3 encompasses genera some unique bacterial genera of eNF and eLF groups, while group 4 includes genera specific to NF and LF. Correlations among these bacterial genera were analyzed (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S7</a>b). Interestingly, positive relationships among bacterial genera within the same group were observed, whereas bacteria communities in groups 2–4 exhibited mutually antagonistic relationships, as indicated by negative correlations among them.</p></div></div><div><h2 id=\"Sec27\">Discussion</h2><div><p>FMT plays a therapeutic role in diseases by reshaping host gut microbiota, and its efficacy is primarily dependent on donor characteristics, recipient condition, and the delivery process of fecal transplants [<a target=\"_blank\" title=\"Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host Microbe. 2023;31:712–33.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR4\">4</a>]. There are multiple studies focusing on studying the role of the gut microbiota composition of the fecal donor on FMT success [<a target=\"_blank\" title=\"He R, Li P, Wang J, Cui B, Zhang F, Zhao F. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation. Gut Microbes. 2022;14:2100197.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR42\">42</a>], with the aim to find a “super donor”. <i>P. pentosaceus</i> Li05, as a probiotic, has proven to be a favorable gut microbiota modulator and gut epithelial homeostasis maintainer [<a target=\"_blank\" title=\"Lv L, Hu X, Qian G, Zhang H, Lu H, Zheng B, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by d-galactosamine in rats. Appl Microbiol Biotechnol. 2014;98:5619–32.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR26\">26</a>, <a target=\"_blank\" title=\"Shi D, Lv L, Fang D, Wu W, Hu C, Xu L, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Sci Rep. 2017;7:6927.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR43\">43</a>,<a target=\"_blank\" title=\"Xie J, Yao M, Lu Y, Yu M, Han S, McClements DJ, et al. Impact of encapsulating a probiotic ( Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infections. Food Funct. 2021;12:3180–90.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR44\">44</a>,<a target=\"_blank\" title=\"Bian X, Yang L, Wu W, Lv L, Jiang X, Wang Q, et al. Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model. Microb Biotechnol. 2020;13:1228–44.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR45\">45</a>,<a target=\"_blank\" title=\"Xu Q, Gu S, Chen Y, Quan J, Lv L, Chen D, et al. Protective effect of Pediococcus pentosaceus LI05 against Clostridium difficile Infection in a Mouse Model. Front Microbiol. 2018;9:2396.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR46\">46</a>,<a target=\"_blank\" title=\"Jiang S, Xia J, Lv L, Wang Q, Li Y, Xu Q, et al. Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats. Food Funct. 2021;12:5077–86.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR47\">47</a>]. Therefore, this study investigated how probiotic intake by donors affected the quality of fecal transplants and evaluated the impact of Li05-modulated microbiota on gut epithelial development and barrier function.</p><p>Gut microbiota form complex microbial networks that influence host health through the exchange of nutrient, energy, and information among microbes [<a target=\"_blank\" title=\"Montoya JM, Pimm SL, Solé RV. Ecological networks and their fragility. Nature. 2006;442:259–64.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR48\">48</a>]. The introduction of probiotics may coordinate the network of interactions [<a target=\"_blank\" title=\"Cao X, Dong A, Kang G, Wang X, Duan L, Hou H, et al. Modeling spatial interaction networks of the gut microbiota. Gut Microbes. 2022;14:2106103.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR49\">49</a>]. With the supplementary of Li05, gut microbiota co-occurrence network topology dramatically changed. Co-occurrence network of gut microbiota in N group maintained a random network during a period of 14 days, indicating ecological network structure sustained a dynamic balance via species interactions and adaptations. With Li05 intervention, gut microbiota co-occurrence network in L group initially displayed a scale-free network on day 1, characterized by a small number of nodes (hub nodes) with high connectivity. By day 3, the network transitioned to a random network, persisting through day 14, reflecting a return to dynamic balance. A healthy gut microbiome, while stable, may undergo transient perturbations from external factors, potentially reverting or evolving into a new stable state [<a target=\"_blank\" title=\"Lee S, Meslier V, Bidkhori G, Garcia-Guevara F, Etienne-Mesmin L, Clasen F, et al. Transient colonizing microbes promote gut dysbiosis and functional impairment. Npj Biofilms Microbiomes. 2024;10:80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR36\">36</a>, <a target=\"_blank\" title=\"Markey L, Pugliese A, Tian T, Roy F, Lee K, Kumamoto CA. Decreased ecological resistance of the gut microbiota in response to clindamycin challenge in mice colonized with the fungus Candida albicans. mSphere. 2021;6:\n                  https://doi.org/10.1128/msphere.00982-20\n                .\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR50\">50</a>]. Li05 intervention, as a perturbing factor for the gut microbiota, altered the stability of the gut microbiota as well as the bacterial interaction network. High modularity indicates increased network stability [<a target=\"_blank\" title=\"Newman MEJ. Modularity and community structure in networks. Proc Natl Acad Sci USA. 2006;103:8577–82.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR51\">51</a>]. The modularity of L group was significantly lower than that of N group, which indicated obvious perturbation of stability of gut microbiota after Li05 intervention. However, the network gradually regained stability, forming a distinct structure separated from that of N group by day 14. In co-occurrence network of gut microbiota, the L group showed fewer nodes but more edges, higher average degree and clustering coefficients than the N group, indicating enhanced bacterial interaction complexity after Li05 intervention [<a target=\"_blank\" title=\"Kajihara KT, Hynson NA. Networks as tools for defining emergent properties of microbiomes and their stability. Microbiome. 2024;12:184.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR52\">52</a>].</p><p>To understand how common microbial community changed, we explored the stability of the gut microbiota among mice of 2 groups by monitoring longitudinal shifts in their microbiomes. Bacterial genera were classified into PCG or TCG. We found that PCG-PCG interactions accounted for the major part of the bacterial interactions, which have been reported to be involved in the core metabolic processes of gut microbiome with high growth rates in the host niche [<a target=\"_blank\" title=\"Lee S, Meslier V, Bidkhori G, Garcia-Guevara F, Etienne-Mesmin L, Clasen F, et al. Transient colonizing microbes promote gut dysbiosis and functional impairment. Npj Biofilms Microbiomes. 2024;10:80.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR36\">36</a>].Li05 supplementation increased the number of TCG, altering gut microbiota stability and facilitating the establishment of a new balanced state during 14 days.</p><p>N and L were used as original donors in the subsequent studies. Although there is currently no consensus on the optimal amount or delivery mode of the fecal transplants, achieving a sufficient bacterial load and high diversity is pivotal for successful colonization and therapeutic efficacy of FMT in vivo [<a target=\"_blank\" title=\"Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host Microbe. 2023;31:712–33.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR4\">4</a>]. Many bacterial species are extremely sensitivity to oxygen, low pH, digestive enzymes, and bile salts, resulting in loss of viability during delivery. Hence, in our study, fecal microbiota was microencapsulated before transplantation. Besides, GF mice serve as hosts for studying host-microbiota interactions. The results demonstrated that transplantation of encapsulated microbiota improved body weight, colon length, and colon crypt depth in mice. Moreover, it increased the expression of tight junction proteins, and the number of goblet cells, Lgr5<sup>+</sup> stem cells, and Ki67<sup>+</sup> cells in the colon. Colonic Lgr5<sup>+</sup> stem cells are known for their potential for long-term self-renewal and maintenance of epithelial integrity [<a target=\"_blank\" title=\"Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastro Hepat. 2019;16:19–34.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR53\">53</a>, <a target=\"_blank\" title=\"Ritsma L, Ellenbroek SI, Zomer A, Snippert HJ, de Sauvage FJ, Simons BD, et al. Intestinal crypt homeostasis revealed at single stem cell level by in vivo live-imaging. Nature. 2014;507:362.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR54\">54</a>], and Ki67 serves as a marker of cell proliferation. Elevated expression of Lgr5 and Ki67 suggested colonic cells undergo continuous cell cycling [<a target=\"_blank\" title=\"Basak O, van de Born M, Korving J, Beumer J, van der Elst S, van Es JH, et al. Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP allele. Embo J. 2014;33:2057.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR55\">55</a>] that expedite epithelial renewal, which is crucial for maintaining gut epithelial homeostasis [<a target=\"_blank\" title=\"Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR56\">56</a>]. Furthermore, Lgr5 + stem cells serve as precursors for goblet cells, which secrete mucin to sustain the gut barrier function [<a target=\"_blank\" title=\"Biteau B, Hochmuth CE, Jasper H. Maintaining tissue homeostasis: dynamic control of somatic stem cell activity. Cell Stem Cell. 2011;9:402.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR57\">57</a>, <a target=\"_blank\" title=\"Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 2011;32:256–64.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR58\">58</a>]. In our study, the observed increases in both Lgr5<sup>+</sup> cells and goblet cells (secreting mucin) suggest that encapsulated FMT, especially pre-modulated by Li05, significantly improved colonic epithelial self-renewal ability and barrier function. Additionally, the introduced microbiota also influenced the transcriptome profile in mice. Transcriptome profiling identified 17 DEGs positively linked to host features, and the most pronounced difference between encapsulated and unencapsulated groups was in the metabolic pathway.</p><p>Microencapsulation may protect some extremely susceptible bacteria which are important in maintaining gut microbiota and gut epithelial homeostasis. Gut microbiota structure significantly differed among four groups on day 14 after FMT. The abundance of <i>Parabacteroides</i>, <i>Parasutterella</i>, <i>Lachnoclostridium</i>, <i>Muribaculum</i>, and <i>Desulfovibrio</i> are especially high in eLF group. <i>Parabacteroides</i> and <i>Parasutterella</i> were two genera also in a higher level in eNF compared to unencapsulated groups. Since these genera were positively correlated with body weight, colon length, crypt depth, goblet cells, Ki67<sup>+</sup> cells, and tight junctions, they are believed to be key functional bacterial genera. Furthermore, we evaluated the associations among host characteristics, the colon transcriptome and gut microbiota. 16 DEGs were positively related with these key bacterial genera. Some of these DEGs were involved in the synthesis and metabolism of cholesterol, which plays a crucial role in maintaining gut barrier function and balancing the microbial ecology by comprising cell membranes, influencing metabolite production such as bile acids, and modulating colonic cell differentiation and function [<a target=\"_blank\" title=\"Pinelli M, Makdissi S, Scur M, Parsons BD, Baker K, Otley A, et al. Peroxisomal cholesterol metabolism regulates yap-signaling, which maintains intestinal epithelial barrier function and is altered in Crohn’s disease. Cell Death Dis. 2024;15:1–19.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR59\">59</a>,<a target=\"_blank\" title=\"Molinero N, Ruiz L, Sánchez B, Margolles A, Delgado S. Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol. 2019;10:185.\" href=\"https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-025-02204-9#ref-CR60\">60</a>,<a target=\"_blank\" title=\"Wang B, Rong X, Palladino END, Wang J, Fogelman AM, Martín MG, et al. Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis. Cell Stem Cell. 2018;22:206-220.e4.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR61\">61</a>].</p><p>Gut microbiota co-occurrence networks of FMT groups exhibited random networkfeatures on day 4 and day 14, except eNF group showed a scale-free bacterial interaction network on day 14 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig4\">4</a>). A scale-free network implied that the network structure is unstable. It contains hub nodes, of which there are a small number of nodes containing many connections. The structure of network can be altered mainly by manipulating the hub nodes [<a target=\"_blank\" title=\"Li Y, Chen Y, Fan Y, Chen Y, Chen Y. Dynamic network modeling of gut microbiota during Alzheimer’s disease progression in mice. Gut Microbes. 2023;15:2172672.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR62\">62</a>]. In eNF group, we found that <i>Eubacterium xylanophilum</i> group genus belonging to <i>Lachnospiraceae</i> family was the hub node of bacterial co-occurrence network on day 14, which was not found in that on day 4. It may be considered as a “late colonizer” and the delayed colonization may cause instability of the network which change network characteristics during the bacterial community evolution [<a target=\"_blank\" title=\"Urtecho G, Moody T, Huang Y, Sheth RU, Richardson M, Descamps HC, et al. Spatiotemporal dynamics during niche remodeling by super-colonizing microbiota in the mammalian gut. Cell Syst. 2024;15:1002-1017.e4.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR63\">63</a>]. Previous research showed early colonizers in FMT may alter the receiver’s gut biochemical environments which may support the growth of “late colonizers”. Bacteria belonging to <i>Lachnospiraceae</i> family are typical “late colonizers”. Interestingly, some of key bacterial genera ranked as hub nodes in NF group (including <i>Desulfovibrio</i>, <i>Lachnoclostridium</i>, and <i>Parasutterella</i>), LF group (including <i>Muribaculum</i> and <i>Parasutterella</i>), and eNF group (<i>Muribaculum</i>), but none was in the eLF group. It implied that the disturb of these hub bacteria genera may have significant influence on the structure of the scale-free network, but the functional role of bacteria in ecology highly depends on its abundance as previously indicated, especially in the random network [<a target=\"_blank\" title=\"Rivett DW, Bell T. Abundance determines the functional role of bacterial phylotypes in complex communities. Nat Microbiol. 2018;3:767–72.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR64\">64</a>]. When key functional bacterial genera serve as hub nodes in the gut microbiota co-occurrence network, their growth may be constrained by interactions of other bacteria. Thus the competition within the network limited the function of key bacterial genera in highly diverse communities [<a target=\"_blank\" title=\"Hall JPJ, Harrison E, Brockhurst MA. Competitive species interactions constrain abiotic adaptation in a bacterial soil community. Evol Lett. 2018;2:580–9.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR65\">65</a>]. While in relatively low-diversity communities (e.g., low Simpson indices for encapsulated groups on day 14), a larger proportion of species are in low abundance, high-abundance key bacterial genera dominate the ecosystem, facilitating the performance of their special functions [<a target=\"_blank\" title=\"Scheuerl T, Hopkins M, Nowell RW, Rivett DW, Barraclough TG, Bell T. Bacterial adaptation is constrained in complex communities. Nat Commun. 2020;11:754.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR66\">66</a>]. Although they may have less connection with other bacteria genera in gut microbiota co-occurrence network of eLF group, their abundance played a significant role in host-bacteria interaction thereby improving FMT efficacy in maintaining gut epithelial homeostasis [<a target=\"_blank\" title=\"Rivett DW, Bell T. Abundance determines the functional role of bacterial phylotypes in complex communities. Nat Microbiol. 2018;3:767–72.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR64\">64</a>].</p><p>Microbial fermentation processes may produce metabolites which directly interact with the host [<a target=\"_blank\" title=\"Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol. 2021;11:1463–82.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR67\">67</a>, <a target=\"_blank\" title=\"Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262–7.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR68\">68</a>] or create new niches for secondary colonizers [<a target=\"_blank\" title=\"Urtecho G, Moody T, Huang Y, Sheth RU, Richardson M, Descamps HC, et al. Spatiotemporal dynamics during niche remodeling by super-colonizing microbiota in the mammalian gut. Cell Syst. 2024;15:1002-1017.e4.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR63\">63</a>]. To demonstrate how different fecal microbiota affect its metabolism in receiver GF mice, we analyzed gut microbiota metabolic profiles after FMT. Encapsulated microbiota exhibited remarkable differences in lipid metabolomic characteristics, especially in BA metabolites. Specifically, the clustering of the eLF group was significantly distinct from other groups in PLS-DA plot. The levels of total BAs and SBAs were highest in the eLF group among FMT groups. SBA-producing gene (<i>baiCD</i>) cluster abundance in gut microbiota was evaluated since it is responsible for production of SBAs [<a target=\"_blank\" title=\"Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599:458–64.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR69\">69</a>]. The level of <i>baiCD</i> is higher in eLF group, it may result in production of more types of SBAs. Some BAs have been reported to improve energy metabolism, regulate mucosal immunity [<a target=\"_blank\" title=\"Golden JM, Escobar OH, Nguyen MVL, Mallicote MU, Kavarian P, Frey MR, et al. Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms. American J Physiol-Gastrointest Liver Physiol. 2018;315:G259–71.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR70\">70</a>, <a target=\"_blank\" title=\"Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851–61.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR71\">71</a>], and facilitate gut microbial diversity, especially in early life [<a target=\"_blank\" title=\"van Best N, Rolle-Kampczyk U, Schaap FG, Basic M, Olde Damink SWM, Bleich A, et al. Bile acids drive the newborn’s gut microbiota maturation. Nat Commun. 2020;11:3692.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR72\">72</a>]. Here, we summarize 11 key BAs enriched in eNF or eLF that were considered to play a supportive role in maintaining gut epithelial development and barrier function [<a target=\"_blank\" title=\"Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237: 108238.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR73\">73</a>] (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S5</a>). Interestingly, <i>Parasutterella</i> and <i>Muribaculum</i> was shown to be positively related with most of differential BAs. <i>Parasutterella</i> also showed its potential of modulating FAs, but most of them are negatively correlated. The interaction between BA metabolites and the gut microbiota is a possible mechanism by which bacteria play a role in maintaining gut epithelial development and barrier function [<a target=\"_blank\" title=\"Larabi AB, Masson HLP, Bäumler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023;15:2172671.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR74\">74</a>, <a target=\"_blank\" title=\"Wahlström A, Sayin SI, Marschall H-U, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41–50.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR75\">75</a>]. <i>Eubacterium xylanophilum</i> group genus, as the hub node of co-occurrence network in eNF group, negatively correlated with most of the BAs while positively correlated with most of the FAs, which is impossible to be considered as key functional bacterial genera.</p><p>Spore-forming bacteria belonging to the Firmicutes phylum, known as primary producers of SBAs [<a target=\"_blank\" title=\"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21:236–47.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR76\">76</a>]<b>, </b>applied as FMT treatment for treatment of intestinal diseases [<a target=\"_blank\" title=\"Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. New Engl J Med. 2022;386:220–9.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR77\">77</a>]<b>. </b>We further evaluated the role of sporobiota in modulating gut function. We found that transplantation with Li05-modulated sporobiota improved gut epithelial homeostasis in mice, particularly by improving the number of AB/PAS<sup>+</sup> cells, Lgr5<sup>+</sup> cells, and Ki67<sup>+</sup> cells, as well as enhancing the expression of <i>Cldn4</i>. Moreover, DEGs including <i>Ciart</i>, <i>Cnpy1</i>, <i>Cyp51</i>, <i>Gm3776</i>, <i>Gsta1</i>, and <i>Zfp791</i> were positively correlated with these cells. In contrast, mice transplanted without Li05-modulated sporobiota exhibited negative effects.</p><p>The co-occurrence network of both sporobiota groups exhibited similar features networks; they were scale-free network on day 4, but turned into random network on day 14 (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#Fig7\">7</a>d–k). Considering almost all bacteria are capable of forming endospores [<a target=\"_blank\" title=\"Setlow P, Wang S, Li Y-Q. Germination of spores of the orders Bacillales and Clostridiales. Annu Rev Microbiol. 2017;71:459–77.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR78\">78</a>], the germination process of spores may take some time which make these spore-forming bacteria act as “late colonizers”. Besides, high modularity of LS group on day 14 indicated increased network stability of gut microbiota. Gut microbiota between NS and LS groups were compared to clarify the key genera in maintaining gut epithelial development. In all the five key bacteria genera, only <i>Lachnoclostridium</i> was found in a relative high level in LS group, while the abundance of all five genera were very low in NS group. It may indicate <i>Lachnoclostridium</i> was the key functional bacteria in LS group, attributed to Li05 modulation. Furthermore, <i>Lachnoclostridium</i> was found to be positively correlated with βMCA and DCA-GC, thereby enhancing the expression of the <i>Ciart</i>, <i>Cnpy1</i>, and <i>Gm3776</i> genes and modulating cellular development.</p><p>Based on the above results, we classified four functional groups of transplanted microbiota (Fig. <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#MOESM1\">S7</a>): (a) group 1, bacterial genera shared by more than three groups; (b) group 2, spore-forming bacteria can survive and spread under harsh conditions, playing a partial role in promoting gut epithelia development; (c) group 3, bacteria require encapsulation for high abundance in gut microbiota, which exhibited the greatest effect on gut epithelial development and barrier function; (d) group 4, bacteria can survive the FMT process without encapsulation, but are not spores, and less effective in supporting gut epithelial development or barrier function. Key functional bacterial genera, except for <i>Lachnoclostridium</i>, were classified into group 3, which exhibited negative correlations with most of the genera in group 2 and group 4, indicating antagonistic relationships among them. <i>Lachnoclostridium</i> was shared between Li05-modulated sporobiota and Li05-modulated encapsulated microbiota. As the key genus exerting the main function after Li05 modulation, <i>Lachnoclostridium</i> showed positive correlation with some of bacterial genera in group 2. Microbial members of the same “functional group” come from different taxonomic backgrounds, but they exhibited co-occurrence features. Remarkably, correlation among these genera of 4 groups almost negatively, indicating mutual antagonism interaction between competing bacterial groups [<a target=\"_blank\" title=\"Wu G, Xu T, Zhao N, Lam YY, Ding X, Wei D, et al. A core microbiome signature as an indicator of health. Cell. 2024;187:6550-65.e11.\" href=\"https://microbiomejournal.biomedcentral.com/article/10.1186/s40168-025-02204-9#ref-CR79\">79</a>].</p></div></div><div><h2 id=\"Sec28\">Conclusion</h2><div><p>FMT exerts therapeutic effects by remodeling the host’s gut microbiota, with efficacy closely tied to donor characteristics. In this study, <i>Pediococcus pentosaceus</i> Li05 supplementation disrupted the stability of the gut microbiota network, establishing a new, interaction-rich microbial community within 14 days. When this modulated microbiota was microencapsulated and orally administered to recipient mice, it significantly enhanced intestinal functional maturation compared to unencapsulated or non-probiotic-supplemented groups. These benefits are attributed to the high abundance of <i>Parabacteroides</i>, <i>Parasutterella</i>, <i>Lachnoclostridium</i>, <i>Muribaculum</i>, and <i>Desulfovibrio</i>, which were identified as key functional bacteria, and they are drivers of bile acid metabolism alterations. Notably, Li05 supplementation increased <i>Lachnoclostridium</i> abundance within the sporobiota, further strengthening gut barrier function via bile acid modulation. Interestingly, when the gut microbiota is in scale-free networks, the role of hub bacterial genera is paramount, whereas in random networks, the abundance of key bacterial genera plays a crucial role in interacting with the host and remodeling gut epithelium. Collectively, this work demonstrates an optimized FMT strategy: Li05-mediated donor microbiota modulation, combined with microencapsulation, enhances recipient intestinal mucosal barrier function through targeted bile acid metabolic regulation.</p><p>Two limitations warrant acknowledgment. First, while current FMT donor guidelines do not exclude probiotic users, integrating probiotic supplementation into donor eligibility criteria remains contentious and requires further validation. Second, although germ-free murine models elucidated mechanisms of microbial reconstruction, species-specific differences in colonization dynamics and host-microbiota interactions constrain direct translation to clinical settings.</p></div></div>\n                                </div><div><h2 id=\"Bib1\">References</h2><div><ol><li><p>de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020–32.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1136%2Fgutjnl-2021-326789\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35105664\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Gut%20microbiome%20and%20health%3A%20mechanistic%20insights&amp;journal=Gut&amp;doi=10.1136%2Fgutjnl-2021-326789&amp;volume=71&amp;pages=1020-1032&amp;publication_year=2022&amp;author=Vos%2CWM&amp;author=Tilg%2CH&amp;author=Hul%2CM&amp;author=Cani%2CPD\">\n                    Google Scholar</a> \n                </p></li><li><p>Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol. 2022;20:365–80.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41579-021-00667-9\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XmsVGntg%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34992261\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microbiome-based%20therapeutics&amp;journal=Nat%20Rev%20Microbiol&amp;doi=10.1038%2Fs41579-021-00667-9&amp;volume=20&amp;pages=365-380&amp;publication_year=2022&amp;author=Sorbara%2CMT&amp;author=Pamer%2CEG\">\n                    Google Scholar</a> \n                </p></li><li><p>Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854–9.</p><p><a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:STN:280:DyaG1M%2Fit1ShtA%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=13592638\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Fecal%20enema%20as%20an%20adjunct%20in%20the%20treatment%20of%20pseudomembranous%20enterocolitis&amp;journal=Surgery&amp;volume=44&amp;pages=854-859&amp;publication_year=1958&amp;author=Eiseman%2CB&amp;author=Silen%2CW&amp;author=Bascom%2CGS&amp;author=Kauvar%2CAJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Cell Host Microbe. 2023;31:712–33.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.chom.2023.03.020\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXpvVaksrc%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37167953\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Key%20determinants%20of%20success%20in%20fecal%20microbiota%20transplantation%3A%20From%20microbiome%20to%20clinic&amp;journal=Cell%20Host%20Microbe&amp;doi=10.1016%2Fj.chom.2023.03.020&amp;volume=31&amp;pages=712-733&amp;publication_year=2023&amp;author=Porcari%2CS&amp;author=Benech%2CN&amp;author=Valles-Colomer%2CM&amp;author=Segata%2CN&amp;author=Gasbarrini%2CA&amp;author=Cammarota%2CG\">\n                    Google Scholar</a> \n                </p></li><li><p>Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66:569–80.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1136%2Fgutjnl-2016-313017\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28087657\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=European%20consensus%20conference%20on%20faecal%20microbiota%20transplantation%20in%20clinical%20practice&amp;journal=Gut&amp;doi=10.1136%2Fgutjnl-2016-313017&amp;volume=66&amp;pages=569-580&amp;publication_year=2017&amp;author=Cammarota%2CG&amp;author=Ianiro%2CG&amp;author=Tilg%2CH&amp;author=Rajili%C4%87-Stojanovi%C4%87%2CM&amp;author=Kump%2CP&amp;author=Satokari%2CR\">\n                    Google Scholar</a> \n                </p></li><li><p>Parenteral and Enteral Nutrition Branch of Chinese Medical Association, Enhanced recovery after surgery branch of China International Health Care Promotion and Exchange Association, China Microecological Treatment Innovation Alliance, Microecology Committee of Shanghai Preventive Medicine Association. Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation. Chinese J Gastrointest Surg. 2020;23:5–13.</p></li><li><p>Carvalho T. First oral fecal microbiota transplant therapy approved. Nat Med. 2023;29:1581–2.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fd41591-023-00046-2\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXhsFSgtLvN\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37221233\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=First%20oral%20fecal%20microbiota%20transplant%20therapy%20approved&amp;journal=Nat%20Med&amp;doi=10.1038%2Fd41591-023-00046-2&amp;volume=29&amp;pages=1581-1582&amp;publication_year=2023&amp;author=Carvalho%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016;13:508–16.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnrgastro.2016.98\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27329806\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909819\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Understanding%20the%20mechanisms%20of%20faecal%20microbiota%20transplantation&amp;journal=Nat%20Rev%20Gastroenterol%20Hepatol&amp;doi=10.1038%2Fnrgastro.2016.98&amp;volume=13&amp;pages=508-516&amp;publication_year=2016&amp;author=Khoruts%2CA&amp;author=Sadowsky%2CMJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Cheng S, Ma X, Geng S, Jiang X, Li Y, Hu L, et al. Fecal microbiota transplantation beneficially regulates intestinal mucosal autophagy and alleviates gut barrier injury. mSystems. 2018;3:e00137–18.</p></li><li><p>Huang Y, He K, Chen Y. Unraveling interactions between gut epithelium and microbiota using models of intestinal organoids. Infectious Microbes &amp; Diseases. 2024;6:117.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1097%2FIM9.0000000000000153\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Unraveling%20interactions%20between%20gut%20epithelium%20and%20microbiota%20using%20models%20of%20intestinal%20organoids&amp;journal=Infectious%20Microbes%20%26%20Diseases&amp;doi=10.1097%2FIM9.0000000000000153&amp;volume=6&amp;publication_year=2024&amp;author=Huang%2CY&amp;author=He%2CK&amp;author=Chen%2CY\">\n                    Google Scholar</a> \n                </p></li><li><p>Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77–94.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41579-020-0438-4\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFWmurvM\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32968241\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Gut%20microbial%20metabolites%20as%20multi-kingdom%20intermediates&amp;journal=Nat%20Rev%20Microbiol&amp;doi=10.1038%2Fs41579-020-0438-4&amp;volume=19&amp;pages=77-94&amp;publication_year=2021&amp;author=Krautkramer%2CKA&amp;author=Fan%2CJ&amp;author=B%C3%A4ckhed%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>McGovern BH, Ford CB, Henn MR, Pardi DS, Khanna S, Hohmann EL, et al. SER-109, an investigational microbiome drug to reduce recurrence after Clostridioides difficile Infection: lessons learned from a phase 2 trial. Clin Infect Dis. 2021;72:2132–40.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fcid%2Fciaa387\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsFSitb3I\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32255488\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SER-109%2C%20an%20investigational%20microbiome%20drug%20to%20reduce%20recurrence%20after%20Clostridioides%20difficile%20Infection%3A%20lessons%20learned%20from%20a%20phase%202%20trial&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1093%2Fcid%2Fciaa387&amp;volume=72&amp;pages=2132-2140&amp;publication_year=2021&amp;author=McGovern%2CBH&amp;author=Ford%2CCB&amp;author=Henn%2CMR&amp;author=Pardi%2CDS&amp;author=Khanna%2CS&amp;author=Hohmann%2CEL\">\n                    Google Scholar</a> \n                </p></li><li><p>Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2016;315:142–9.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1001%2Fjama.2015.18098\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhtVartbbF\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26757463\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Frozen%20vs%20fresh%20fecal%20microbiota%20transplantation%20and%20clinical%20resolution%20of%20diarrhea%20in%20patients%20with%20recurrent%20Clostridium%20difficile%20infection%3A%20a%20randomized%20clinical%20trial&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2015.18098&amp;volume=315&amp;pages=142-149&amp;publication_year=2016&amp;author=Lee%2CCH&amp;author=Steiner%2CT&amp;author=Petrof%2CEO&amp;author=Smieja%2CM&amp;author=Roscoe%2CD&amp;author=Nematallah%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Yu Y, Wang W, Zhang F. The next generation fecal microbiota transplantation: to transplant bacteria or virome. Adv Sci. 2023;10:2301097.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1002%2Fadvs.202301097\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXit1OntLfJ\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20next%20generation%20fecal%20microbiota%20transplantation%3A%20to%20transplant%20bacteria%20or%20virome&amp;journal=Adv%20Sci&amp;doi=10.1002%2Fadvs.202301097&amp;volume=10&amp;publication_year=2023&amp;author=Yu%2CY&amp;author=Wang%2CW&amp;author=Zhang%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Yang Y, He J, Wang Y, Liang L, Zhang Z, Tan X, et al. Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis. Front Immunol. 2023;14:1143526.</p><p><a target=\"_blank\" href=\"https://doi.org/10.3389%2Ffimmu.2023.1143526\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXht1eksrrM\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37234168\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206398\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Whole%20intestinal%20microbiota%20transplantation%20is%20more%20effective%20than%20fecal%20microbiota%20transplantation%20in%20reducing%20the%20susceptibility%20of%20DSS-induced%20germ-free%20mice%20colitis&amp;journal=Front%20Immunol&amp;doi=10.3389%2Ffimmu.2023.1143526&amp;volume=14&amp;publication_year=2023&amp;author=Yang%2CY&amp;author=He%2CJ&amp;author=Wang%2CY&amp;author=Liang%2CL&amp;author=Zhang%2CZ&amp;author=Tan%2CX\">\n                    Google Scholar</a> \n                </p></li><li><p>Brugiroux S, Beutler M, Pfann C, Garzetti D, Ruscheweyh H-J, Ring D, et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat Microbiol. 2016;2:1–12.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnmicrobiol.2016.215\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Genome-guided%20design%20of%20a%20defined%20mouse%20microbiota%20that%20confers%20colonization%20resistance%20against%20Salmonella%20enterica%20serovar%20Typhimurium&amp;journal=Nat%20Microbiol&amp;doi=10.1038%2Fnmicrobiol.2016.215&amp;volume=2&amp;pages=1-12&amp;publication_year=2016&amp;author=Brugiroux%2CS&amp;author=Beutler%2CM&amp;author=Pfann%2CC&amp;author=Garzetti%2CD&amp;author=Ruscheweyh%2CH-J&amp;author=Ring%2CD\">\n                    Google Scholar</a> \n                </p></li><li><p>Piekarska A, Panasiuk A, Stępień PM. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol—recommendations of the Polish Society od Epidemiology and Infectious Diseases. Przegl Epidemiol. 2020;74:69–87.</p><p><a target=\"_blank\" href=\"https://doi.org/10.32394%2Fpe.74.06\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32500988\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20practice%20guidelines%20for%20Clostridioides%20%28Clostridium%29%20difficile%20infection%20and%20fecal%20microbiota%20transplant%20protocol%E2%80%94recommendations%20of%20the%20Polish%20Society%20od%20Epidemiology%20and%20Infectious%20Diseases&amp;journal=Przegl%20Epidemiol&amp;doi=10.32394%2Fpe.74.06&amp;volume=74&amp;pages=69-87&amp;publication_year=2020&amp;author=Piekarska%2CA&amp;author=Panasiuk%2CA&amp;author=St%C4%99pie%C5%84%2CPM\">\n                    Google Scholar</a> \n                </p></li><li><p>Peery AF, Kelly CR, Kao D, Vaughn BP, Lebwohl B, Singh S, et al. AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology. 2024;166:409–34.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1053%2Fj.gastro.2024.01.008\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXksFGrtrw%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38395525\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=AGA%20clinical%20practice%20guideline%20on%20fecal%20microbiota-based%20therapies%20for%20select%20gastrointestinal%20diseases&amp;journal=Gastroenterology&amp;doi=10.1053%2Fj.gastro.2024.01.008&amp;volume=166&amp;pages=409-434&amp;publication_year=2024&amp;author=Peery%2CAF&amp;author=Kelly%2CCR&amp;author=Kao%2CD&amp;author=Vaughn%2CBP&amp;author=Lebwohl%2CB&amp;author=Singh%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019;68:2111–21.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1136%2Fgutjnl-2019-319548\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXovV2ht7w%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31563878\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=International%20consensus%20conference%20on%20stool%20banking%20for%20faecal%20microbiota%20transplantation%20in%20clinical%20practice&amp;journal=Gut&amp;doi=10.1136%2Fgutjnl-2019-319548&amp;volume=68&amp;pages=2111-2121&amp;publication_year=2019&amp;author=Cammarota%2CG&amp;author=Ianiro%2CG&amp;author=Kelly%2CCR&amp;author=Mullish%2CBH&amp;author=Allegretti%2CJR&amp;author=Kassam%2CZ\">\n                    Google Scholar</a> \n                </p></li><li><p>van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021;27:S1-21.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cmi.2021.09.038\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34678515\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=European%20Society%20of%20Clinical%20Microbiology%20and%20Infectious%20Diseases%3A%202021%20update%20on%20the%20treatment%20guidance%20document%20for%20Clostridioides%20difficile%20infection%20in%20adults&amp;journal=Clin%20Microbiol%20Infect&amp;doi=10.1016%2Fj.cmi.2021.09.038&amp;volume=27&amp;pages=S1-21&amp;publication_year=2021&amp;author=Prehn%2CJ&amp;author=Reigadas%2CE&amp;author=Vogelzang%2CEH&amp;author=Bouza%2CE&amp;author=Hristea%2CA&amp;author=Guery%2CB\">\n                    Google Scholar</a> \n                </p></li><li><p>Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridioides difficile</i> infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2024;73:1–24.</p></li><li><p>Gulati M, Singh SK, Corrie L, Kaur IP, Chandwani L. Delivery routes for faecal microbiota transplants: available, anticipated and aspired. Pharmacol Res. 2020;159: 104954.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.phrs.2020.104954\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32492490\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Delivery%20routes%20for%20faecal%20microbiota%20transplants%3A%20available%2C%20anticipated%20and%20aspired&amp;journal=Pharmacol%20Res&amp;doi=10.1016%2Fj.phrs.2020.104954&amp;volume=159&amp;publication_year=2020&amp;author=Gulati%2CM&amp;author=Singh%2CSK&amp;author=Corrie%2CL&amp;author=Kaur%2CIP&amp;author=Chandwani%2CL\">\n                    Google Scholar</a> \n                </p></li><li><p>Lee JY, Kim Y, Kim J, Kim JK. Fecal microbiota transplantation: indications, methods, and challenges. J Microbiol. 2024;62:1057–74.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1007/s12275-024-00184-3\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39557804\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Fecal%20microbiota%20transplantation%3A%20indications%2C%20methods%2C%20and%20challenges&amp;journal=J%20Microbiol&amp;doi=10.1007%2Fs12275-024-00184-3&amp;volume=62&amp;pages=1057-1074&amp;publication_year=2024&amp;author=Lee%2CJY&amp;author=Kim%2CY&amp;author=Kim%2CJ&amp;author=Kim%2CJK\">\n                    Google Scholar</a> \n                </p></li><li><p>Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ, et al. Fecal microbiota transplantation: current challenges and future landscapes. Staley C, editor. Clin Microbiol Rev. 2024;37:e00060–22.</p></li><li><p>Jiang S, Cai L, Lv L, Li L. Pediococcus pentosaceus, a future additive or probiotic candidate. Microb Cell Fact. 2021;20:45.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/s12934-021-01537-y\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXkslSju78%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33593360\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885583\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Pediococcus%20pentosaceus%2C%20a%20future%20additive%20or%20probiotic%20candidate&amp;journal=Microb%20Cell%20Fact&amp;doi=10.1186%2Fs12934-021-01537-y&amp;volume=20&amp;publication_year=2021&amp;author=Jiang%2CS&amp;author=Cai%2CL&amp;author=Lv%2CL&amp;author=Li%2CL\">\n                    Google Scholar</a> \n                </p></li><li><p>Lv L, Hu X, Qian G, Zhang H, Lu H, Zheng B, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by d-galactosamine in rats. Appl Microbiol Biotechnol. 2014;98:5619–32.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1007/s00253-014-5638-2\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXksFyksbk%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24639205\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Administration%20of%20Lactobacillus%20salivarius%20LI01%20or%20Pediococcus%20pentosaceus%20LI05%20improves%20acute%20liver%20injury%20induced%20by%20d-galactosamine%20in%20rats&amp;journal=Appl%20Microbiol%20Biotechnol&amp;doi=10.1007%2Fs00253-014-5638-2&amp;volume=98&amp;pages=5619-5632&amp;publication_year=2014&amp;author=Lv%2CL&amp;author=Hu%2CX&amp;author=Qian%2CG&amp;author=Zhang%2CH&amp;author=Lu%2CH&amp;author=Zheng%2CB\">\n                    Google Scholar</a> \n                </p></li><li><p>Koransky JR, Allen SD, Dowell VR. Use of ethanol for selective isolation of sporeforming microorganisms. Appl Environ Microbiol. 1978;35:762–5.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1128%2Faem.35.4.762-765.1978\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DyaE1cXksFCjsrg%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=348108\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC242919\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Use%20of%20ethanol%20for%20selective%20isolation%20of%20sporeforming%20microorganisms&amp;journal=Appl%20Environ%20Microbiol&amp;doi=10.1128%2Faem.35.4.762-765.1978&amp;volume=35&amp;pages=762-765&amp;publication_year=1978&amp;author=Koransky%2CJR&amp;author=Allen%2CSD&amp;author=Dowell%2CVR\">\n                    Google Scholar</a> \n                </p></li><li><p>Minekus M, Alminger M, Alvito P, Ballance S, Bohn T, Bourlieu C, et al. A standardised static <i>in vitro</i> digestion method suitable for food—an international consensus. Food Funct. 2014;5:1113–24.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1039%2FC3FO60702J\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXovVanur4%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24803111\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=A%20standardised%20static%20in%20vitro%20digestion%20method%20suitable%20for%20food%E2%80%94an%20international%20consensus&amp;journal=Food%20Funct&amp;doi=10.1039%2FC3FO60702J&amp;volume=5&amp;pages=1113-1124&amp;publication_year=2014&amp;author=Minekus%2CM&amp;author=Alminger%2CM&amp;author=Alvito%2CP&amp;author=Ballance%2CS&amp;author=Bohn%2CT&amp;author=Bourlieu%2CC\">\n                    Google Scholar</a> \n                </p></li><li><p>Yao M, Wu J, Li B, Xiao H, McClements DJ, Li L. Microencapsulation of Lactobacillus salivarious Li01 for enhanced storage viability and targeted delivery to gut microbiota. Food Hydrocolloids. 2017;72:228–36.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.foodhyd.2017.05.033\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXpslGmu7g%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microencapsulation%20of%20Lactobacillus%20salivarious%20Li01%20for%20enhanced%20storage%20viability%20and%20targeted%20delivery%20to%20gut%20microbiota&amp;journal=Food%20Hydrocolloids&amp;doi=10.1016%2Fj.foodhyd.2017.05.033&amp;volume=72&amp;pages=228-236&amp;publication_year=2017&amp;author=Yao%2CM&amp;author=Wu%2CJ&amp;author=Li%2CB&amp;author=Xiao%2CH&amp;author=McClements%2CDJ&amp;author=Li%2CL\">\n                    Google Scholar</a> \n                </p></li><li><p>Qv L, Yang Z, Yao M, Mao S, Li Y, Zhang J, et al. Methods for establishment and maintenance of germ-free rat models. Front Microbiol. 2020;11:1148.</p></li><li><p>Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnmeth.3869\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC28XosVWitb4%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27214047\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927377\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=DADA2%3A%20High%20resolution%20sample%20inference%20from%20Illumina%20amplicon%20data&amp;journal=Nat%20Methods&amp;doi=10.1038%2Fnmeth.3869&amp;volume=13&amp;pages=581-583&amp;publication_year=2016&amp;author=Callahan%2CBJ&amp;author=McMurdie%2CPJ&amp;author=Rosen%2CMJ&amp;author=Han%2CAW&amp;author=Johnson%2CAJA&amp;author=Holmes%2CSP\">\n                    Google Scholar</a> \n                </p></li><li><p>Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852–7.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41587-019-0209-9\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXhsVeksr%2FO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31341288\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015180\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Reproducible%2C%20interactive%2C%20scalable%20and%20extensible%20microbiome%20data%20science%20using%20QIIME%202&amp;journal=Nat%20Biotechnol&amp;doi=10.1038%2Fs41587-019-0209-9&amp;volume=37&amp;pages=852-857&amp;publication_year=2019&amp;author=Bolyen%2CE&amp;author=Rideout%2CJR&amp;author=Dillon%2CMR&amp;author=Bokulich%2CNA&amp;author=Abnet%2CCC&amp;author=Al-Ghalith%2CGA\">\n                    Google Scholar</a> \n                </p></li><li><p>Liu J, Zhu S, Liu X, Yao P, Ge T, Zhang X-H. Spatiotemporal dynamics of the archaeal community in coastal sediments: assembly process and co-occurrence relationship. ISME J. 2020;14:1463–78.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41396-020-0621-7\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32132664\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242467\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Spatiotemporal%20dynamics%20of%20the%20archaeal%20community%20in%20coastal%20sediments%3A%20assembly%20process%20and%20co-occurrence%20relationship&amp;journal=ISME%20J&amp;doi=10.1038%2Fs41396-020-0621-7&amp;volume=14&amp;pages=1463-1478&amp;publication_year=2020&amp;author=Liu%2CJ&amp;author=Zhu%2CS&amp;author=Liu%2CX&amp;author=Yao%2CP&amp;author=Ge%2CT&amp;author=Zhang%2CX-H\">\n                    Google Scholar</a> \n                </p></li><li><p>Li M, Raza M, Song S, Hou L, Zhang Z-F, Gao M, et al. Application of culturomics in fungal isolation from mangrove sediments. Microbiome. 2023;11:272.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/s40168-023-01708-6\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXisF2isrjP\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38082427\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712113\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Application%20of%20culturomics%20in%20fungal%20isolation%20from%20mangrove%20sediments&amp;journal=Microbiome&amp;doi=10.1186%2Fs40168-023-01708-6&amp;volume=11&amp;publication_year=2023&amp;author=Li%2CM&amp;author=Raza%2CM&amp;author=Song%2CS&amp;author=Hou%2CL&amp;author=Zhang%2CZ-F&amp;author=Gao%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. Proceedings of the International AAAI Conference on Web and Social Media. 2009;3:361–2.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1609%2Ficwsm.v3i1.13937\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Gephi%3A%20an%20open%20source%20software%20for%20exploring%20and%20manipulating%20networks&amp;journal=Proceedings%20of%20the%20International%20AAAI%20Conference%20on%20Web%20and%20Social%20Media&amp;doi=10.1609%2Ficwsm.v3i1.13937&amp;volume=3&amp;pages=361-362&amp;publication_year=2009&amp;author=Bastian%2CM&amp;author=Heymann%2CS&amp;author=Jacomy%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Lee S, Meslier V, Bidkhori G, Garcia-Guevara F, Etienne-Mesmin L, Clasen F, et al. Transient colonizing microbes promote gut dysbiosis and functional impairment. Npj Biofilms Microbiomes. 2024;10:80.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41522-024-00561-1\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39245657\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11381545\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Transient%20colonizing%20microbes%20promote%20gut%20dysbiosis%20and%20functional%20impairment&amp;journal=Npj%20Biofilms%20Microbiomes&amp;doi=10.1038%2Fs41522-024-00561-1&amp;volume=10&amp;publication_year=2024&amp;author=Lee%2CS&amp;author=Meslier%2CV&amp;author=Bidkhori%2CG&amp;author=Garcia-Guevara%2CF&amp;author=Etienne-Mesmin%2CL&amp;author=Clasen%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357–60.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnmeth.3317\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXjvFOnsL0%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25751142\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655817\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=HISAT%3A%20a%20fast%20spliced%20aligner%20with%20low%20memory%20requirements&amp;journal=Nat%20Methods&amp;doi=10.1038%2Fnmeth.3317&amp;volume=12&amp;pages=357-360&amp;publication_year=2015&amp;author=Kim%2CD&amp;author=Langmead%2CB&amp;author=Salzberg%2CSL\">\n                    Google Scholar</a> \n                </p></li><li><p>Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinform. 2022;38:2943–5.</p></li><li><p>Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/gb-2010-11-10-r106\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsVahs7bI\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20979621\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218662\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Differential%20expression%20analysis%20for%20sequence%20count%20data&amp;journal=Genome%20Biol&amp;doi=10.1186%2Fgb-2010-11-10-r106&amp;volume=11&amp;publication_year=2010&amp;author=Anders%2CS&amp;author=Huber%2CW\">\n                    Google Scholar</a> \n                </p></li><li><p>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fbioinformatics%2Fbtp616\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXhs1WlurvO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19910308\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=edgeR%3A%20a%20Bioconductor%20package%20for%20differential%20expression%20analysis%20of%20digital%20gene%20expression%20data&amp;journal=Bioinformatics&amp;doi=10.1093%2Fbioinformatics%2Fbtp616&amp;volume=26&amp;pages=139-140&amp;publication_year=2010&amp;author=Robinson%2CMD&amp;author=McCarthy%2CDJ&amp;author=Smyth%2CGK\">\n                    Google Scholar</a> \n                </p></li><li><p>Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27:29–34.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1093%2Fnar%2F27.1.29\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DyaK1MXpsVGltw%3D%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9847135\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC148090\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=KEGG%3A%20Kyoto%20Encyclopedia%20of%20Genes%20and%20Genomes&amp;journal=Nucleic%20Acids%20Res&amp;doi=10.1093%2Fnar%2F27.1.29&amp;volume=27&amp;pages=29-34&amp;publication_year=1999&amp;author=Ogata%2CH&amp;author=Goto%2CS&amp;author=Sato%2CK&amp;author=Fujibuchi%2CW&amp;author=Bono%2CH&amp;author=Kanehisa%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>He R, Li P, Wang J, Cui B, Zhang F, Zhao F. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation. Gut Microbes. 2022;14:2100197.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1080%2F19490976.2022.2100197\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35854629\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302524\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20interplay%20of%20gut%20microbiota%20between%20donors%20and%20recipients%20determines%20the%20efficacy%20of%20fecal%20microbiota%20transplantation&amp;journal=Gut%20Microbes&amp;doi=10.1080%2F19490976.2022.2100197&amp;volume=14&amp;publication_year=2022&amp;author=He%2CR&amp;author=Li%2CP&amp;author=Wang%2CJ&amp;author=Cui%2CB&amp;author=Zhang%2CF&amp;author=Zhao%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Shi D, Lv L, Fang D, Wu W, Hu C, Xu L, et al. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Sci Rep. 2017;7:6927.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41598-017-07091-1\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28761060\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537250\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Administration%20of%20Lactobacillus%20salivarius%20LI01%20or%20Pediococcus%20pentosaceus%20LI05%20prevents%20CCl4-induced%20liver%20cirrhosis%20by%20protecting%20the%20intestinal%20barrier%20in%20rats&amp;journal=Sci%20Rep&amp;doi=10.1038%2Fs41598-017-07091-1&amp;volume=7&amp;publication_year=2017&amp;author=Shi%2CD&amp;author=Lv%2CL&amp;author=Fang%2CD&amp;author=Wu%2CW&amp;author=Hu%2CC&amp;author=Xu%2CL\">\n                    Google Scholar</a> \n                </p></li><li><p>Xie J, Yao M, Lu Y, Yu M, Han S, McClements DJ, et al. Impact of encapsulating a probiotic ( <i>Pediococcus pentosaceus</i> Li05) within gastro-responsive microgels on <i>Clostridium difficile</i> infections. Food Funct. 2021;12:3180–90.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1039%2FD0FO03235B\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXltlSht7Y%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33734244\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20encapsulating%20a%20probiotic%20%28%20Pediococcus%20pentosaceus%20Li05%29%20within%20gastro-responsive%20microgels%20on%20Clostridium%20difficile%20infections&amp;journal=Food%20Funct&amp;doi=10.1039%2FD0FO03235B&amp;volume=12&amp;pages=3180-3190&amp;publication_year=2021&amp;author=Xie%2CJ&amp;author=Yao%2CM&amp;author=Lu%2CY&amp;author=Yu%2CM&amp;author=Han%2CS&amp;author=McClements%2CDJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Bian X, Yang L, Wu W, Lv L, Jiang X, Wang Q, et al. Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model. Microb Biotechnol. 2020;13:1228–44.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1111%2F1751-7915.13583\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFaiur3J\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32363766\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264873\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Pediococcus%20pentosaceus%20LI05%20alleviates%20DSS-induced%20colitis%20by%20modulating%20immunological%20profiles%2C%20the%20gut%20microbiota%20and%20short-chain%20fatty%20acid%20levels%20in%20a%20mouse%20model&amp;journal=Microb%20Biotechnol&amp;doi=10.1111%2F1751-7915.13583&amp;volume=13&amp;pages=1228-1244&amp;publication_year=2020&amp;author=Bian%2CX&amp;author=Yang%2CL&amp;author=Wu%2CW&amp;author=Lv%2CL&amp;author=Jiang%2CX&amp;author=Wang%2CQ\">\n                    Google Scholar</a> \n                </p></li><li><p>Xu Q, Gu S, Chen Y, Quan J, Lv L, Chen D, et al. Protective effect of Pediococcus pentosaceus LI05 against Clostridium difficile Infection in a Mouse Model. Front Microbiol. 2018;9:2396.</p><p><a target=\"_blank\" href=\"https://doi.org/10.3389%2Ffmicb.2018.02396\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30356740\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189400\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Protective%20effect%20of%20Pediococcus%20pentosaceus%20LI05%20against%20Clostridium%20difficile%20Infection%20in%20a%20Mouse%20Model&amp;journal=Front%20Microbiol&amp;doi=10.3389%2Ffmicb.2018.02396&amp;volume=9&amp;publication_year=2018&amp;author=Xu%2CQ&amp;author=Gu%2CS&amp;author=Chen%2CY&amp;author=Quan%2CJ&amp;author=Lv%2CL&amp;author=Chen%2CD\">\n                    Google Scholar</a> \n                </p></li><li><p>Jiang S, Xia J, Lv L, Wang Q, Li Y, Xu Q, et al. Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats. Food Funct. 2021;12:5077–86.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1039%2FD0FO02530E\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXptFWhsr8%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33960989\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Effects%20of%20Pediococcus%20pentosaceus%20LI05%20on%20immunity%20and%20metabolism%20in%20germ-free%20rats&amp;journal=Food%20Funct&amp;doi=10.1039%2FD0FO02530E&amp;volume=12&amp;pages=5077-5086&amp;publication_year=2021&amp;author=Jiang%2CS&amp;author=Xia%2CJ&amp;author=Lv%2CL&amp;author=Wang%2CQ&amp;author=Li%2CY&amp;author=Xu%2CQ\">\n                    Google Scholar</a> \n                </p></li><li><p>Montoya JM, Pimm SL, Solé RV. Ecological networks and their fragility. Nature. 2006;442:259–64.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnature04927\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD28XmvF2jsrc%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16855581\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Ecological%20networks%20and%20their%20fragility&amp;journal=Nature&amp;doi=10.1038%2Fnature04927&amp;volume=442&amp;pages=259-264&amp;publication_year=2006&amp;author=Montoya%2CJM&amp;author=Pimm%2CSL&amp;author=Sol%C3%A9%2CRV\">\n                    Google Scholar</a> \n                </p></li><li><p>Cao X, Dong A, Kang G, Wang X, Duan L, Hou H, et al. Modeling spatial interaction networks of the gut microbiota. Gut Microbes. 2022;14:2106103.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1080%2F19490976.2022.2106103\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35921525\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351588\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Modeling%20spatial%20interaction%20networks%20of%20the%20gut%20microbiota&amp;journal=Gut%20Microbes&amp;doi=10.1080%2F19490976.2022.2106103&amp;volume=14&amp;publication_year=2022&amp;author=Cao%2CX&amp;author=Dong%2CA&amp;author=Kang%2CG&amp;author=Wang%2CX&amp;author=Duan%2CL&amp;author=Hou%2CH\">\n                    Google Scholar</a> \n                </p></li><li><p>Markey L, Pugliese A, Tian T, Roy F, Lee K, Kumamoto CA. Decreased ecological resistance of the gut microbiota in response to clindamycin challenge in mice colonized with the fungus Candida albicans. mSphere. 2021;6:<a target=\"_blank\" href=\"https://doi.org/10.1128/msphere.00982-20\">https://doi.org/10.1128/msphere.00982-20</a>.</p></li><li><p>Newman MEJ. Modularity and community structure in networks. Proc Natl Acad Sci USA. 2006;103:8577–82.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1073%2Fpnas.0601602103\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD28XlvVCitLw%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16723398\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482622\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Modularity%20and%20community%20structure%20in%20networks&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;doi=10.1073%2Fpnas.0601602103&amp;volume=103&amp;pages=8577-8582&amp;publication_year=2006&amp;author=Newman%2CMEJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Kajihara KT, Hynson NA. Networks as tools for defining emergent properties of microbiomes and their stability. Microbiome. 2024;12:184.</p><p><a target=\"_blank\" href=\"https://link.springer.com/doi/10.1186/s40168-024-01868-z\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39342398\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439251\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Networks%20as%20tools%20for%20defining%20emergent%20properties%20of%20microbiomes%20and%20their%20stability&amp;journal=Microbiome&amp;doi=10.1186%2Fs40168-024-01868-z&amp;volume=12&amp;publication_year=2024&amp;author=Kajihara%2CKT&amp;author=Hynson%2CNA\">\n                    Google Scholar</a> \n                </p></li><li><p>Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastro Hepat. 2019;16:19–34.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41575-018-0081-y\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Tales%20from%20the%20crypt%3A%20new%20insights%20into%20intestinal%20stem%20cells&amp;journal=Nat%20Rev%20Gastro%20Hepat&amp;doi=10.1038%2Fs41575-018-0081-y&amp;volume=16&amp;pages=19-34&amp;publication_year=2019&amp;author=Gehart%2CH&amp;author=Clevers%2CH\">\n                    Google Scholar</a> \n                </p></li><li><p>Ritsma L, Ellenbroek SI, Zomer A, Snippert HJ, de Sauvage FJ, Simons BD, et al. Intestinal crypt homeostasis revealed at single stem cell level by in vivo live-imaging. Nature. 2014;507:362.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnature12972\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXks1WktLo%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24531760\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964820\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Intestinal%20crypt%20homeostasis%20revealed%20at%20single%20stem%20cell%20level%20by%20in%20vivo%20live-imaging&amp;journal=Nature&amp;doi=10.1038%2Fnature12972&amp;volume=507&amp;publication_year=2014&amp;author=Ritsma%2CL&amp;author=Ellenbroek%2CSI&amp;author=Zomer%2CA&amp;author=Snippert%2CHJ&amp;author=Sauvage%2CFJ&amp;author=Simons%2CBD\">\n                    Google Scholar</a> \n                </p></li><li><p>Basak O, van de Born M, Korving J, Beumer J, van der Elst S, van Es JH, et al. Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP allele. Embo J. 2014;33:2057.</p><p><a target=\"_blank\" href=\"https://doi.org/10.15252%2Fembj.201488017\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvV2nsLnF\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25092767\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195772\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Mapping%20early%20fate%20determination%20in%20Lgr5%2B%20crypt%20stem%20cells%20using%20a%20novel%20Ki67-RFP%20allele&amp;journal=Embo%20J&amp;doi=10.15252%2Fembj.201488017&amp;volume=33&amp;publication_year=2014&amp;author=Basak%2CO&amp;author=Born%2CM&amp;author=Korving%2CJ&amp;author=Beumer%2CJ&amp;author=Elst%2CS&amp;author=Es%2CJH\">\n                    Google Scholar</a> \n                </p></li><li><p>Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fnrm3721\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXhvFSktr%2FK\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24326621\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Adult%20intestinal%20stem%20cells%3A%20critical%20drivers%20of%20epithelial%20homeostasis%20and%20regeneration&amp;journal=Nat%20Rev%20Mol%20Cell%20Biol&amp;doi=10.1038%2Fnrm3721&amp;volume=15&amp;pages=19-33&amp;publication_year=2014&amp;author=Barker%2CN\">\n                    Google Scholar</a> \n                </p></li><li><p>Biteau B, Hochmuth CE, Jasper H. Maintaining tissue homeostasis: dynamic control of somatic stem cell activity. Cell Stem Cell. 2011;9:402.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.stem.2011.10.004\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXhsVarsb3N\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22056138\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212030\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Maintaining%20tissue%20homeostasis%3A%20dynamic%20control%20of%20somatic%20stem%20cell%20activity&amp;journal=Cell%20Stem%20Cell&amp;doi=10.1016%2Fj.stem.2011.10.004&amp;volume=9&amp;publication_year=2011&amp;author=Biteau%2CB&amp;author=Hochmuth%2CCE&amp;author=Jasper%2CH\">\n                    Google Scholar</a> \n                </p></li><li><p>Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 2011;32:256–64.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.it.2011.04.003\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3MXntFSmsrk%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21565554\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20intestinal%20epithelial%20barrier%20in%20the%20control%20of%20homeostasis%20and%20immunity&amp;journal=Trends%20Immunol&amp;doi=10.1016%2Fj.it.2011.04.003&amp;volume=32&amp;pages=256-264&amp;publication_year=2011&amp;author=Rescigno%2CM\">\n                    Google Scholar</a> \n                </p></li><li><p>Pinelli M, Makdissi S, Scur M, Parsons BD, Baker K, Otley A, et al. Peroxisomal cholesterol metabolism regulates yap-signaling, which maintains intestinal epithelial barrier function and is altered in Crohn’s disease. Cell Death Dis. 2024;15:1–19.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41419-024-06925-x\">Article</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Peroxisomal%20cholesterol%20metabolism%20regulates%20yap-signaling%2C%20which%20maintains%20intestinal%20epithelial%20barrier%20function%20and%20is%20altered%20in%20Crohn%E2%80%99s%20disease&amp;journal=Cell%20Death%20Dis&amp;doi=10.1038%2Fs41419-024-06925-x&amp;volume=15&amp;pages=1-19&amp;publication_year=2024&amp;author=Pinelli%2CM&amp;author=Makdissi%2CS&amp;author=Scur%2CM&amp;author=Parsons%2CBD&amp;author=Baker%2CK&amp;author=Otley%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Molinero N, Ruiz L, Sánchez B, Margolles A, Delgado S. Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol. 2019;10:185.</p><p><a target=\"_blank\" href=\"https://doi.org/10.3389%2Ffphys.2019.00185\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30923502\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426790\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Intestinal%20bacteria%20interplay%20with%20bile%20and%20cholesterol%20metabolism%3A%20implications%20on%20host%20physiology&amp;journal=Front%20Physiol&amp;doi=10.3389%2Ffphys.2019.00185&amp;volume=10&amp;publication_year=2019&amp;author=Molinero%2CN&amp;author=Ruiz%2CL&amp;author=S%C3%A1nchez%2CB&amp;author=Margolles%2CA&amp;author=Delgado%2CS\">\n                    Google Scholar</a> \n                </p></li><li><p>Wang B, Rong X, Palladino END, Wang J, Fogelman AM, Martín MG, et al. Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis. Cell Stem Cell. 2018;22:206-220.e4.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.stem.2017.12.017\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXisVSit7g%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29395055\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807072\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Phospholipid%20remodeling%20and%20cholesterol%20availability%20regulate%20intestinal%20stemness%20and%20tumorigenesis&amp;journal=Cell%20Stem%20Cell&amp;doi=10.1016%2Fj.stem.2017.12.017&amp;volume=22&amp;pages=206-220.e4&amp;publication_year=2018&amp;author=Wang%2CB&amp;author=Rong%2CX&amp;author=Palladino%2CEND&amp;author=Wang%2CJ&amp;author=Fogelman%2CAM&amp;author=Mart%C3%ADn%2CMG\">\n                    Google Scholar</a> \n                </p></li><li><p>Li Y, Chen Y, Fan Y, Chen Y, Chen Y. Dynamic network modeling of gut microbiota during Alzheimer’s disease progression in mice. Gut Microbes. 2023;15:2172672.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1080%2F19490976.2023.2172672\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=36724123\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897752\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Dynamic%20network%20modeling%20of%20gut%20microbiota%20during%20Alzheimer%E2%80%99s%20disease%20progression%20in%20mice&amp;journal=Gut%20Microbes&amp;doi=10.1080%2F19490976.2023.2172672&amp;volume=15&amp;publication_year=2023&amp;author=Li%2CY&amp;author=Chen%2CY&amp;author=Fan%2CY&amp;author=Chen%2CY&amp;author=Chen%2CY\">\n                    Google Scholar</a> \n                </p></li><li><p>Urtecho G, Moody T, Huang Y, Sheth RU, Richardson M, Descamps HC, et al. Spatiotemporal dynamics during niche remodeling by super-colonizing microbiota in the mammalian gut. Cell Syst. 2024;15:1002-1017.e4.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cels.2024.10.007\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXisV2htLnE\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39541983\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066173\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Spatiotemporal%20dynamics%20during%20niche%20remodeling%20by%20super-colonizing%20microbiota%20in%20the%20mammalian%20gut&amp;journal=Cell%20Syst&amp;doi=10.1016%2Fj.cels.2024.10.007&amp;volume=15&amp;pages=1002-1017.e4&amp;publication_year=2024&amp;author=Urtecho%2CG&amp;author=Moody%2CT&amp;author=Huang%2CY&amp;author=Sheth%2CRU&amp;author=Richardson%2CM&amp;author=Descamps%2CHC\">\n                    Google Scholar</a> \n                </p></li><li><p>Rivett DW, Bell T. Abundance determines the functional role of bacterial phylotypes in complex communities. Nat Microbiol. 2018;3:767–72.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41564-018-0180-0\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFGksLvO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29915204\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065991\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Abundance%20determines%20the%20functional%20role%20of%20bacterial%20phylotypes%20in%20complex%20communities&amp;journal=Nat%20Microbiol&amp;doi=10.1038%2Fs41564-018-0180-0&amp;volume=3&amp;pages=767-772&amp;publication_year=2018&amp;author=Rivett%2CDW&amp;author=Bell%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Hall JPJ, Harrison E, Brockhurst MA. Competitive species interactions constrain abiotic adaptation in a bacterial soil community. Evol Lett. 2018;2:580–9.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1002%2Fevl3.83\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30564441\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292705\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Competitive%20species%20interactions%20constrain%20abiotic%20adaptation%20in%20a%20bacterial%20soil%20community&amp;journal=Evol%20Lett&amp;doi=10.1002%2Fevl3.83&amp;volume=2&amp;pages=580-589&amp;publication_year=2018&amp;author=Hall%2CJPJ&amp;author=Harrison%2CE&amp;author=Brockhurst%2CMA\">\n                    Google Scholar</a> \n                </p></li><li><p>Scheuerl T, Hopkins M, Nowell RW, Rivett DW, Barraclough TG, Bell T. Bacterial adaptation is constrained in complex communities. Nat Commun. 2020;11:754.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41467-020-14570-z\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXjs1OhtrY%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32029713\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005322\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Bacterial%20adaptation%20is%20constrained%20in%20complex%20communities&amp;journal=Nat%20Commun&amp;doi=10.1038%2Fs41467-020-14570-z&amp;volume=11&amp;publication_year=2020&amp;author=Scheuerl%2CT&amp;author=Hopkins%2CM&amp;author=Nowell%2CRW&amp;author=Rivett%2CDW&amp;author=Barraclough%2CTG&amp;author=Bell%2CT\">\n                    Google Scholar</a> \n                </p></li><li><p>Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol. 2021;11:1463–82.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.jcmgh.2021.02.007\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhtlSru7zO\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33610769\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025057\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20intestinal%20barrier%20function%20by%20microbial%20metabolites&amp;journal=Cell%20Mol%20Gastroenterol%20Hepatol&amp;doi=10.1016%2Fj.jcmgh.2021.02.007&amp;volume=11&amp;pages=1463-1482&amp;publication_year=2021&amp;author=Ghosh%2CS&amp;author=Whitley%2CCS&amp;author=Haribabu%2CB&amp;author=Jala%2CVR\">\n                    Google Scholar</a> \n                </p></li><li><p>Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262–7.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1126%2Fscience.1223813\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC38XnvFekt7c%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22674330\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Host-gut%20microbiota%20metabolic%20interactions&amp;journal=Science&amp;doi=10.1126%2Fscience.1223813&amp;volume=336&amp;pages=1262-1267&amp;publication_year=2012&amp;author=Nicholson%2CJK&amp;author=Holmes%2CE&amp;author=Kinross%2CJ&amp;author=Burcelin%2CR&amp;author=Gibson%2CG&amp;author=Jia%2CW\">\n                    Google Scholar</a> \n                </p></li><li><p>Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599:458–64.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41586-021-03832-5\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFSqsL7N\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34325466\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Novel%20bile%20acid%20biosynthetic%20pathways%20are%20enriched%20in%20the%20microbiome%20of%20centenarians&amp;journal=Nature&amp;doi=10.1038%2Fs41586-021-03832-5&amp;volume=599&amp;pages=458-464&amp;publication_year=2021&amp;author=Sato%2CY&amp;author=Atarashi%2CK&amp;author=Plichta%2CDR&amp;author=Arai%2CY&amp;author=Sasajima%2CS&amp;author=Kearney%2CSM\">\n                    Google Scholar</a> \n                </p></li><li><p>Golden JM, Escobar OH, Nguyen MVL, Mallicote MU, Kavarian P, Frey MR, et al. Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms. American J Physiol-Gastrointest Liver Physiol. 2018;315:G259–71.</p></li><li><p>Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851–61.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41385-019-0162-4\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXot12rtbs%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30952999\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Emerging%20roles%20of%20bile%20acids%20in%20mucosal%20immunity%20and%20inflammation&amp;journal=Mucosal%20Immunol&amp;doi=10.1038%2Fs41385-019-0162-4&amp;volume=12&amp;pages=851-861&amp;publication_year=2019&amp;author=Chen%2CML&amp;author=Takeda%2CK&amp;author=Sundrud%2CMS\">\n                    Google Scholar</a> \n                </p></li><li><p>van Best N, Rolle-Kampczyk U, Schaap FG, Basic M, Olde Damink SWM, Bleich A, et al. Bile acids drive the newborn’s gut microbiota maturation. Nat Commun. 2020;11:3692.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41467-020-17183-8\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32703946\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378201\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Bile%20acids%20drive%20the%20newborn%E2%80%99s%20gut%20microbiota%20maturation&amp;journal=Nat%20Commun&amp;doi=10.1038%2Fs41467-020-17183-8&amp;volume=11&amp;publication_year=2020&amp;author=Best%2CN&amp;author=Rolle-Kampczyk%2CU&amp;author=Schaap%2CFG&amp;author=Basic%2CM&amp;author=Olde%20Damink%2CSWM&amp;author=Bleich%2CA\">\n                    Google Scholar</a> \n                </p></li><li><p>Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237: 108238.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.pharmthera.2022.108238\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XitVKns7nL\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35792223\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Bile%20acid%20metabolism%20and%20signaling%2C%20the%20microbiota%2C%20and%20metabolic%20disease&amp;journal=Pharmacol%20Ther&amp;doi=10.1016%2Fj.pharmthera.2022.108238&amp;volume=237&amp;publication_year=2022&amp;author=Cai%2CJ&amp;author=Rimal%2CB&amp;author=Jiang%2CC&amp;author=Chiang%2CJYL&amp;author=Patterson%2CAD\">\n                    Google Scholar</a> \n                </p></li><li><p>Larabi AB, Masson HLP, Bäumler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023;15:2172671.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1080%2F19490976.2023.2172671\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=36740850\">PubMed</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904317\">PubMed Central</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Bile%20acids%20as%20modulators%20of%20gut%20microbiota%20composition%20and%20function&amp;journal=Gut%20Microbes&amp;doi=10.1080%2F19490976.2023.2172671&amp;volume=15&amp;publication_year=2023&amp;author=Larabi%2CAB&amp;author=Masson%2CHLP&amp;author=B%C3%A4umler%2CAJ\">\n                    Google Scholar</a> \n                </p></li><li><p>Wahlström A, Sayin SI, Marschall H-U, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41–50.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1016%2Fj.cmet.2016.05.005\">Article</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27320064\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Intestinal%20crosstalk%20between%20bile%20acids%20and%20microbiota%20and%20its%20impact%20on%20host%20metabolism&amp;journal=Cell%20Metab&amp;doi=10.1016%2Fj.cmet.2016.05.005&amp;volume=24&amp;pages=41-50&amp;publication_year=2016&amp;author=Wahlstr%C3%B6m%2CA&amp;author=Sayin%2CSI&amp;author=Marschall%2CH-U&amp;author=B%C3%A4ckhed%2CF\">\n                    Google Scholar</a> \n                </p></li><li><p>Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21:236–47.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1038%2Fs41579-022-00805-x\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xis1GlsL7K\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=36253479\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Bile%20acids%20and%20the%20gut%20microbiota%3A%20metabolic%20interactions%20and%20impacts%20on%20disease&amp;journal=Nat%20Rev%20Microbiol&amp;doi=10.1038%2Fs41579-022-00805-x&amp;volume=21&amp;pages=236-247&amp;publication_year=2023&amp;author=Collins%2CSL&amp;author=Stine%2CJG&amp;author=Bisanz%2CJE&amp;author=Okafor%2CCD&amp;author=Patterson%2CAD\">\n                    Google Scholar</a> \n                </p></li><li><p>Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, et al. SER-109, an oral microbiome therapy for recurrent <i>Clostridioides difficile</i> infection. New Engl J Med. 2022;386:220–9.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1056%2FNEJMoa2106516\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhvV2gtrY%3D\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35045228\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=SER-109%2C%20an%20oral%20microbiome%20therapy%20for%20recurrent%20Clostridioides%20difficile%20infection&amp;journal=New%20Engl%20J%20Med&amp;doi=10.1056%2FNEJMoa2106516&amp;volume=386&amp;pages=220-229&amp;publication_year=2022&amp;author=Feuerstadt%2CP&amp;author=Louie%2CTJ&amp;author=Lashner%2CB&amp;author=Wang%2CEEL&amp;author=Diao%2CL&amp;author=Bryant%2CJA\">\n                    Google Scholar</a> \n                </p></li><li><p>Setlow P, Wang S, Li Y-Q. Germination of spores of the orders Bacillales and Clostridiales. Annu Rev Microbiol. 2017;71:459–77.</p><p><a target=\"_blank\" href=\"https://doi.org/10.1146%2Fannurev-micro-090816-093558\">Article</a> \n    <a target=\"_blank\" href=\"https://microbiomejournal.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtFGmt73N\">CAS</a> \n    <a target=\"_blank\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28697670\">PubMed</a> \n    <a target=\"_blank\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Germination%20of%20spores%20of%20the%20orders%20Bacillales%20and%20Clostridiales&amp;journal=Annu%20Rev%20Microbiol&amp;doi=10.1146%2Fannurev-micro-090816-093558&amp;volume=71&amp;pages=459-477&amp;publication_year=2017&amp;author=Setlow%2CP&amp;author=Wang%2CS&amp;author=Li%2CY-Q\">\n                    Google Scholar</a> \n                </p></li><li><p>Wu G, Xu T, Zhao N, Lam YY, Ding X, Wei D, et al. A core microbiome signature as an indicator of health. Cell. 2024;187:6550-65.e11.</p></li></ol><p><a target=\"_blank\" href=\"https://citation-needed.springer.com/v2/references/10.1186/s40168-025-02204-9?format=refman&amp;flavour=references\">Download references</a></p></div></div>",
  "author": "Yao, Mingfei",
  "favicon": "https://microbiomejournal.biomedcentral.com/oscar-static/img/favicons/darwin/favicon-de0c289efe.ico",
  "source": "microbiomejournal.biomedcentral.com",
  "published": "2025-10-22",
  "ttr": 2557,
  "type": "article"
}